Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Index by author

April 01, 2002; Volume 301,Issue 1
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Abrahamsen, Christian T.

    1. You have access
      The Angiotensin Type 1 Receptor Antagonist, Eprosartan, Attenuates the Progression of Renal Disease in Spontaneously Hypertensive Stroke-Prone Rats with Accelerated Hypertension
      Christian T. Abrahamsen, Frank C. Barone, Wallace G. Campbell, Allen H. Nelson, Lisa C. Contino, Mark A. Pullen, Eugene T. Grygielko, Richard M. Edwards, Nicholas J. Laping and David P. Brooks
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 21-28; DOI: https://doi.org/10.1124/jpet.301.1.21
  2. Acquaah-Mensah, George K.

    1. You have access
      In Utero Ethanol Suppresses Cerebellar Activator Protein-1 and Nuclear Factor-κB Transcriptional Activation in a Rat Fetal Alcohol Syndrome Model
      George K. Acquaah-Mensah, James P. Kehrer and Steven W. Leslie
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 277-283; DOI: https://doi.org/10.1124/jpet.301.1.277
  3. Adams, Jerry

    1. You have access
      Sustained Activation of p38 Mitogen-Activated Protein Kinase Contributes to the Vascular Response to Injury
      Haisong Ju, Sandhya Nerurkar, Charles F. Sauermelch, Alan R. Olzinski, Rosanna Mirabile, Dawn Zimmerman, John C. Lee, Jerry Adams, Joseph Sisko, Marinella Berova and Robert N. Willette
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 15-20; DOI: https://doi.org/10.1124/jpet.301.1.15
  4. Adler, G.

    1. You have access
      In Vivo α1-Adrenergic Lipolytic Activity in Subcutaneous Adipose Tissue of Obese Subjects
      M. Flechtner-Mors, C. P. Jenkinson, A. Alt, G. Adler and H. H. Ditschuneit
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 229-233; DOI: https://doi.org/10.1124/jpet.301.1.229
  5. Afify, Elham A.

    1. You have access
      Cyclosporine Adversely Affects Baroreflexes via Inhibition of Testosterone Modulation of Cardiac Vagal Control
      Mahmoud M. El-Mas, Elham A. Afify, Amal G. Omar and Fouad M. Sharabi
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 346-354; DOI: https://doi.org/10.1124/jpet.301.1.346
  6. Alt, A.

    1. You have access
      In Vivo α1-Adrenergic Lipolytic Activity in Subcutaneous Adipose Tissue of Obese Subjects
      M. Flechtner-Mors, C. P. Jenkinson, A. Alt, G. Adler and H. H. Ditschuneit
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 229-233; DOI: https://doi.org/10.1124/jpet.301.1.229
  7. Altar, C. Anthony

    1. You have access
      Attenuation of Scopolamine-Induced and Age-Associated Memory Impairments by the Sigma and 5-Hydroxytryptamine1A Receptor Agonist OPC-14523 (1-{3-[4-(3-chlorophenyl)-1-piperazinyl]propyl}-5-methoxy-3,4-dihydro-2[1H]-quinolinone monomethanesulfonate)
      Katsura Tottori, Masami Nakai, Yasufumi Uwahodo, Takashi Miwa, Sakiko Yamada, Yasuo Oshiro, Tetsuro Kikuchi and C. Anthony Altar
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 249-257; DOI: https://doi.org/10.1124/jpet.301.1.249
  8. Aschner, Michael

    1. You have access
      Pharmacology and Toxicology of Astrocyte-Neuron Glutamate Transport and Cycling
      Ursula Sonnewald, Hong Qu and Michael Aschner
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 1-6; DOI: https://doi.org/10.1124/jpet.301.1.1
  9. Asher, Orna

    1. You have access
      Ethanol Stimulates cAMP-Responsive Element (CRE)-Mediated Transcription via CRE-Binding Protein and cAMP-Dependent Protein Kinase
      Orna Asher, Thomas D. Cunningham, Lina Yao, Adrienne S. Gordon and Ivan Diamond
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 66-70; DOI: https://doi.org/10.1124/jpet.301.1.66
  10. Aubert, Michel L.

    1. You have access
      Pharmacological Profile of a New, Potent, and Long-Acting Gonadotropin-Releasing Hormone Antagonist: Degarelix
      Pierre Broqua, Pierre J.-M. Riviere, P. Michael Conn, Jean E. Rivier, Michel L. Aubert and Jean-Louis Junien
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 95-102; DOI: https://doi.org/10.1124/jpet.301.1.95

B

  1. Backman, Janne T.

    1. You have access
      Dose Optimization of a Doxorubicin Prodrug (HMR 1826) in Isolated Perfused Human Lungs: Low Tumor pH Promotes Prodrug Activation by β-Glucuronidase
      Thomas E. Mürdter, Godehard Friedel, Janne T. Backman, Monika McClellan, Monika Schick, Manfred Gerken, Klaus Bosslet, Peter Fritz, Heikki Toomes, Heyo K. Kroemer and Bernhard Sperker
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 223-228; DOI: https://doi.org/10.1124/jpet.301.1.223
  2. Bai, Jingxiang

    1. You have access
      Adenovirus-Mediated Overexpression of Catalase in the Cytosolic or Mitochondrial Compartment Protects against Toxicity Caused by Glutathione Depletion in HepG2 Cells Expressing CYP2E1
      Montserrat Marı́, Jingxiang Bai and Arthur I. Cederbaum
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 111-118; DOI: https://doi.org/10.1124/jpet.301.1.111
  3. Baker, John D.

    1. You have access
      Influence of Porcine Actinobacillus pleuropneumoniae Infection and Dexamethasone on the Pharmacokinetic Parameters of Enrofloxacin
      Lynn O. Post, Carol V. Cope, Dorothy E. Farrell, John D. Baker and Michael J. Myers
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 217-222; DOI: https://doi.org/10.1124/jpet.301.1.217
  4. Barone, Frank C.

    1. You have access
      The Angiotensin Type 1 Receptor Antagonist, Eprosartan, Attenuates the Progression of Renal Disease in Spontaneously Hypertensive Stroke-Prone Rats with Accelerated Hypertension
      Christian T. Abrahamsen, Frank C. Barone, Wallace G. Campbell, Allen H. Nelson, Lisa C. Contino, Mark A. Pullen, Eugene T. Grygielko, Richard M. Edwards, Nicholas J. Laping and David P. Brooks
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 21-28; DOI: https://doi.org/10.1124/jpet.301.1.21
  5. Berger, Michael

    1. You have access
      Tranexamic Acid, a Widely Used Antifibrinolytic Agent, Causes Convulsions by a γ-Aminobutyric AcidA Receptor Antagonistic Effect
      Roman Furtmüller, Michael G. Schlag, Michael Berger, Rudolf Hopf, Sigismund Huck, Werner Sieghart and Heinz Redl
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 168-173; DOI: https://doi.org/10.1124/jpet.301.1.168
  6. Berova, Marinella

    1. You have access
      Sustained Activation of p38 Mitogen-Activated Protein Kinase Contributes to the Vascular Response to Injury
      Haisong Ju, Sandhya Nerurkar, Charles F. Sauermelch, Alan R. Olzinski, Rosanna Mirabile, Dawn Zimmerman, John C. Lee, Jerry Adams, Joseph Sisko, Marinella Berova and Robert N. Willette
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 15-20; DOI: https://doi.org/10.1124/jpet.301.1.15
  7. Blumer, Jeffrey L.

    1. You have access
      Kinetic Interactions of Dopamine and Dobutamine with Human Catechol-O-methyltransferase and Monoamine Oxidase in Vitro
      Maohe Yan, Leslie T. Webster and Jeffrey L. Blumer
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 315-321; DOI: https://doi.org/10.1124/jpet.301.1.315
  8. Boichot, Elisabeth

    1. You have access
      The Selective Phosphodiesterase 4 Inhibitor RP 73-401 Reduced Matrix Metalloproteinase 9 Activity and Transforming Growth Factor-β Release During Acute Lung Injury in Mice: The Role of the Balance Between Tumor Necrosis Factor-α and Interleukin-10
      Marianne Corbel, Noëlla Germain, Jérôme Lanchou, Sophie Molet, Patricia M. R. e Silva, Marco A. Martins, Elisabeth Boichot and Vincent Lagente
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 258-265; DOI: https://doi.org/10.1124/jpet.301.1.258
  9. Bosslet, Klaus

    1. You have access
      Dose Optimization of a Doxorubicin Prodrug (HMR 1826) in Isolated Perfused Human Lungs: Low Tumor pH Promotes Prodrug Activation by β-Glucuronidase
      Thomas E. Mürdter, Godehard Friedel, Janne T. Backman, Monika McClellan, Monika Schick, Manfred Gerken, Klaus Bosslet, Peter Fritz, Heikki Toomes, Heyo K. Kroemer and Bernhard Sperker
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 223-228; DOI: https://doi.org/10.1124/jpet.301.1.223
  10. Boyadjieva, Nadka

    1. You have access
      Role of Protein Kinase C in Control of Ethanol-Modulated β-Endorphin Release from Hypothalamic Neurons in Primary Cultures
      Alok De, Nadka Boyadjieva and Dipak K. Sarkar
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 119-128; DOI: https://doi.org/10.1124/jpet.301.1.119
  11. Brodde, Otto-Erich

    1. You have access
      Differential Effects of Bucindolol and Carvedilol on Noradenaline-Induced Hypertrophic Response in Ventricular Cardiomyocytes of Adult Rats
      Klaus Pönicke, Ingrid Heinroth-Hoffmann and Otto-Erich Brodde
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 71-76; DOI: https://doi.org/10.1124/jpet.301.1.71
  12. Brooks, David P.

    1. You have access
      The Angiotensin Type 1 Receptor Antagonist, Eprosartan, Attenuates the Progression of Renal Disease in Spontaneously Hypertensive Stroke-Prone Rats with Accelerated Hypertension
      Christian T. Abrahamsen, Frank C. Barone, Wallace G. Campbell, Allen H. Nelson, Lisa C. Contino, Mark A. Pullen, Eugene T. Grygielko, Richard M. Edwards, Nicholas J. Laping and David P. Brooks
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 21-28; DOI: https://doi.org/10.1124/jpet.301.1.21
  13. Broqua, Pierre

    1. You have access
      Pharmacological Profile of a New, Potent, and Long-Acting Gonadotropin-Releasing Hormone Antagonist: Degarelix
      Pierre Broqua, Pierre J.-M. Riviere, P. Michael Conn, Jean E. Rivier, Michel L. Aubert and Jean-Louis Junien
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 95-102; DOI: https://doi.org/10.1124/jpet.301.1.95
  14. Buccafusco, J. J.

    1. You have access
      Effects of (±)-4-{[2-(1-Methyl-2-pyrrolidinyl)ethyl]thio}phenol Hydrochloride (SIB-1553A), a Selective Ligand for Nicotinic Acetylcholine Receptors, in Tests of Visual Attention and Distractibility in Rats and Monkeys
      A. V. Terry, V. B. Risbrough, J. J. Buccafusco and F. Menzaghi
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 284-292; DOI: https://doi.org/10.1124/jpet.301.1.284
  15. Buist, Susan C. N.

    1. You have access
      Gender-Specific and Developmental Influences on the Expression of Rat Organic Anion Transporters
      Susan C. N. Buist, Nathan J. Cherrington, Supratim Choudhuri, Dylan P. Hartley and Curtis D. Klaassen
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 145-151; DOI: https://doi.org/10.1124/jpet.301.1.145
  16. Burchell, B.

    1. You have access
      In Vitro Analysis of Human Drug Glucuronidation and Prediction of in Vivo Metabolic Clearance
      M. G. Soars, B. Burchell and R. J. Riley
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 382-390; DOI: https://doi.org/10.1124/jpet.301.1.382
  17. Burda, Jozef

    1. You have access
      Prevention of in Vivo Excitotoxicity by a Family of Trialkylglycines, a Novel Class of Neuroprotectants
      Carmina Montoliu, Marc Humet, Juan-José Canales, Jozef Burda, Rosa Planells-Cases, Francisco Sánchez-Baeza, Teresa Carbonell, Enrique Pérez-Payá, Angel Messeguer, Antonio Ferrer-Montiel and Vicente Felipo
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 29-36; DOI: https://doi.org/10.1124/jpet.301.1.29

C

  1. Campbell, Wallace G.

    1. You have access
      The Angiotensin Type 1 Receptor Antagonist, Eprosartan, Attenuates the Progression of Renal Disease in Spontaneously Hypertensive Stroke-Prone Rats with Accelerated Hypertension
      Christian T. Abrahamsen, Frank C. Barone, Wallace G. Campbell, Allen H. Nelson, Lisa C. Contino, Mark A. Pullen, Eugene T. Grygielko, Richard M. Edwards, Nicholas J. Laping and David P. Brooks
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 21-28; DOI: https://doi.org/10.1124/jpet.301.1.21
  2. Canales, Juan-José

    1. You have access
      Prevention of in Vivo Excitotoxicity by a Family of Trialkylglycines, a Novel Class of Neuroprotectants
      Carmina Montoliu, Marc Humet, Juan-José Canales, Jozef Burda, Rosa Planells-Cases, Francisco Sánchez-Baeza, Teresa Carbonell, Enrique Pérez-Payá, Angel Messeguer, Antonio Ferrer-Montiel and Vicente Felipo
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 29-36; DOI: https://doi.org/10.1124/jpet.301.1.29
  3. Carbonell, Teresa

    1. You have access
      Prevention of in Vivo Excitotoxicity by a Family of Trialkylglycines, a Novel Class of Neuroprotectants
      Carmina Montoliu, Marc Humet, Juan-José Canales, Jozef Burda, Rosa Planells-Cases, Francisco Sánchez-Baeza, Teresa Carbonell, Enrique Pérez-Payá, Angel Messeguer, Antonio Ferrer-Montiel and Vicente Felipo
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 29-36; DOI: https://doi.org/10.1124/jpet.301.1.29
  4. Cederbaum, Arthur I.

    1. You have access
      Adenovirus-Mediated Overexpression of Catalase in the Cytosolic or Mitochondrial Compartment Protects against Toxicity Caused by Glutathione Depletion in HepG2 Cells Expressing CYP2E1
      Montserrat Marı́, Jingxiang Bai and Arthur I. Cederbaum
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 111-118; DOI: https://doi.org/10.1124/jpet.301.1.111
  5. Cherrington, Nathan J.

    1. You have access
      Gender-Specific and Developmental Influences on the Expression of Rat Organic Anion Transporters
      Susan C. N. Buist, Nathan J. Cherrington, Supratim Choudhuri, Dylan P. Hartley and Curtis D. Klaassen
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 145-151; DOI: https://doi.org/10.1124/jpet.301.1.145
  6. Chiba, Tsutomu

    1. You have access
      New Cytokine Delivery System Using Gelatin Microspheres Containing Interleukin-10 for Experimental Inflammatory Bowel Disease
      Hiroshi Nakase, Kazuichi Okazaki, Yasuhiko Tabata, Makoto Ozeki, Norihiko Watanabe, Masaya Ohana, Suguru Uose, Kazushige Uchida, Toshiki Nishi, Minoru Mastuura, Hiroyuki Tamaki, Toshiyuki Itoh, Chiharu Kawanami and Tsutomu Chiba
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 59-65; DOI: https://doi.org/10.1124/jpet.301.1.59
  7. Chopin, Philippe

    1. You have access
      Effects of Acute and Subchronic Administration of Dexefaroxan, an α2-Adrenoceptor Antagonist, on Memory Performance in Young Adult and Aged Rodents
      Philippe Chopin, Francis C. Colpaert and Marc Marien
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 187-196; DOI: https://doi.org/10.1124/jpet.301.1.187
  8. Chou, Tsai-Fwu

    1. You have access
      Differential Effects of Sarcolemmal and Mitochondrial KATP Channels Activated by 17β-Estradiol on Reperfusion Arrhythmias and Infarct Sizes in Canine Hearts
      Chang-Her Tsai, Sheng-Fang Su, Tsai-Fwu Chou and Tsung-Ming Lee
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 234-240; DOI: https://doi.org/10.1124/jpet.301.1.234
  9. Choudhuri, Supratim

    1. You have access
      Gender-Specific and Developmental Influences on the Expression of Rat Organic Anion Transporters
      Susan C. N. Buist, Nathan J. Cherrington, Supratim Choudhuri, Dylan P. Hartley and Curtis D. Klaassen
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 145-151; DOI: https://doi.org/10.1124/jpet.301.1.145
  10. Collins, Eric D.

    1. You have access
      Intravenous Buprenorphine Self-Administration by Detoxified Heroin Abusers
      Sandra D. Comer, Eric D. Collins and Marian W. Fischman
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 266-276; DOI: https://doi.org/10.1124/jpet.301.1.266
  11. Colpaert, Francis C.

    1. You have access
      Effects of Acute and Subchronic Administration of Dexefaroxan, an α2-Adrenoceptor Antagonist, on Memory Performance in Young Adult and Aged Rodents
      Philippe Chopin, Francis C. Colpaert and Marc Marien
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 187-196; DOI: https://doi.org/10.1124/jpet.301.1.187
  12. Comer, Sandra D.

    1. You have access
      Intravenous Buprenorphine Self-Administration by Detoxified Heroin Abusers
      Sandra D. Comer, Eric D. Collins and Marian W. Fischman
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 266-276; DOI: https://doi.org/10.1124/jpet.301.1.266
  13. Conn, P. Michael

    1. You have access
      Pharmacological Profile of a New, Potent, and Long-Acting Gonadotropin-Releasing Hormone Antagonist: Degarelix
      Pierre Broqua, Pierre J.-M. Riviere, P. Michael Conn, Jean E. Rivier, Michel L. Aubert and Jean-Louis Junien
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 95-102; DOI: https://doi.org/10.1124/jpet.301.1.95
  14. Contino, Lisa C.

    1. You have access
      The Angiotensin Type 1 Receptor Antagonist, Eprosartan, Attenuates the Progression of Renal Disease in Spontaneously Hypertensive Stroke-Prone Rats with Accelerated Hypertension
      Christian T. Abrahamsen, Frank C. Barone, Wallace G. Campbell, Allen H. Nelson, Lisa C. Contino, Mark A. Pullen, Eugene T. Grygielko, Richard M. Edwards, Nicholas J. Laping and David P. Brooks
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 21-28; DOI: https://doi.org/10.1124/jpet.301.1.21
  15. Cope, Carol V.

    1. You have access
      Influence of Porcine Actinobacillus pleuropneumoniae Infection and Dexamethasone on the Pharmacokinetic Parameters of Enrofloxacin
      Lynn O. Post, Carol V. Cope, Dorothy E. Farrell, John D. Baker and Michael J. Myers
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 217-222; DOI: https://doi.org/10.1124/jpet.301.1.217
  16. Corbel, Marianne

    1. You have access
      The Selective Phosphodiesterase 4 Inhibitor RP 73-401 Reduced Matrix Metalloproteinase 9 Activity and Transforming Growth Factor-β Release During Acute Lung Injury in Mice: The Role of the Balance Between Tumor Necrosis Factor-α and Interleukin-10
      Marianne Corbel, Noëlla Germain, Jérôme Lanchou, Sophie Molet, Patricia M. R. e Silva, Marco A. Martins, Elisabeth Boichot and Vincent Lagente
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 258-265; DOI: https://doi.org/10.1124/jpet.301.1.258
  17. Cotecchia, Susanna

    1. You have access
      β1-Selective Agonist (−)-1-(3,4-Dimethoxyphenetylamino)-3-(3,4-dihydroxy)-2-propanol [(−)-RO363] Differentially Interacts with Key Amino Acids Responsible for β1-Selective Binding in Resting and Active States
      Yoshiyuki Sugimoto, Reiko Fujisawa, Ryuji Tanimura, Anne Laure Lattion, Susanna Cotecchia, Gozoh Tsujimoto, Taku Nagao and Hitoshi Kurose
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 51-58; DOI: https://doi.org/10.1124/jpet.301.1.51
  18. Coy, David H.

    1. You have access
      Elucidation of Vasoactive Intestinal Peptide Pharmacophore for VPAC1 Receptors in Human, Rat, and Guinea Pig
      Hisato Igarashi, Tetsuhide Ito, Wei Hou, Samuel A. Mantey, Tapas K. Pradhan, Charles D. Ulrich, Simon J. Hocart, David H. Coy and Robert T. Jensen
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 37-50; DOI: https://doi.org/10.1124/jpet.301.1.37
  19. Cunningham, Thomas D.

    1. You have access
      Ethanol Stimulates cAMP-Responsive Element (CRE)-Mediated Transcription via CRE-Binding Protein and cAMP-Dependent Protein Kinase
      Orna Asher, Thomas D. Cunningham, Lina Yao, Adrienne S. Gordon and Ivan Diamond
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 66-70; DOI: https://doi.org/10.1124/jpet.301.1.66

D

  1. Darre, Valerie

    1. You have access
      4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine Hydrochloride (SSR125543A): A Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. I. Biochemical and Pharmacological Characterization
      Danielle Gully, Michel Geslin, Laurence Serva, Evelyne Fontaine, Pierre Roger, Christine Lair, Valerie Darre, Claudine Marcy, Pierre-Eric Rouby, Jacques Simiand, Josette Guitard, Georgette Gout, Regis Steinberg, Daniel Rodier, Guy Griebel, Philippe Soubrie, Marc Pascal, Rebecca Pruss, Bernard Scatton, Jean-Pierre Maffrand and Gerard Le Fur
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 322-332; DOI: https://doi.org/10.1124/jpet.301.1.322
  2. Darvesh, Altaf S.

    1. You have access
      3,4-Methylenedioxymethamphetamine Produces Glycogenolysis and Increases the Extracellular Concentration of Glucose in the Rat Brain
      Altaf S. Darvesh, Mahalakshmi Shankaran and Gary A. Gudelsky
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 138-144; DOI: https://doi.org/10.1124/jpet.301.1.138
  3. Davis, S. S.

    1. You have access
      Intranasal Delivery of Morphine
      L. Illum, P. Watts, A. N. Fisher, M. Hinchcliffe, H. Norbury, I. Jabbal-Gill, R. Nankervis and S. S. Davis
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 391-400; DOI: https://doi.org/10.1124/jpet.301.1.391
  4. De, Alok

    1. You have access
      Role of Protein Kinase C in Control of Ethanol-Modulated β-Endorphin Release from Hypothalamic Neurons in Primary Cultures
      Alok De, Nadka Boyadjieva and Dipak K. Sarkar
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 119-128; DOI: https://doi.org/10.1124/jpet.301.1.119
  5. Deitch, Edwin A.

    1. You have access
      Inhibitors of ATP-Binding Cassette Transporters Suppress Interleukin-12 p40 Production and Major Histocompatibility Complex II Up-Regulation in Macrophages
      György Haskó, Edwin A. Deitch, Zoltán H. Németh, David G. Kuhel and Csaba Szabó
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 103-110; DOI: https://doi.org/10.1124/jpet.301.1.103
  6. Delcarpio, Joseph

    1. You have access
      Cardiovascular Responses Elicited by the “Binge” Administration of Methamphetamine
      Kurt J. Varner, Brian A. Ogden, Joseph Delcarpio and Suzanne Meleg-Smith
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 152-159; DOI: https://doi.org/10.1124/jpet.301.1.152
  7. Derbez, Alicia E.

    1. You have access
      ς2-Receptor Regulation of Dopamine Transporter via Activation of Protein Kinase C
      Alicia E. Derbez, Rupal M. Mody and Linda L. Werling
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 306-314; DOI: https://doi.org/10.1124/jpet.301.1.306
  8. Diamond, Ivan

    1. You have access
      Ethanol Stimulates cAMP-Responsive Element (CRE)-Mediated Transcription via CRE-Binding Protein and cAMP-Dependent Protein Kinase
      Orna Asher, Thomas D. Cunningham, Lina Yao, Adrienne S. Gordon and Ivan Diamond
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 66-70; DOI: https://doi.org/10.1124/jpet.301.1.66
  9. Ditschuneit, H. H.

    1. You have access
      In Vivo α1-Adrenergic Lipolytic Activity in Subcutaneous Adipose Tissue of Obese Subjects
      M. Flechtner-Mors, C. P. Jenkinson, A. Alt, G. Adler and H. H. Ditschuneit
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 229-233; DOI: https://doi.org/10.1124/jpet.301.1.229
  10. Dwivedi, Yogesh

    1. You have access
      Differential Effects of Haloperidol and Clozapine on [3H]cAMP Binding, Protein Kinase A (PKA) Activity, and mRNA and Protein Expression of Selective Regulatory and Catalytic Subunit Isoforms of PKA in Rat Brain
      Yogesh Dwivedi, Hooriyah S. Rizavi and Ghanshyam N. Pandey
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 197-209; DOI: https://doi.org/10.1124/jpet.301.1.197

E

  1. Edwards, Richard M.

    1. You have access
      The Angiotensin Type 1 Receptor Antagonist, Eprosartan, Attenuates the Progression of Renal Disease in Spontaneously Hypertensive Stroke-Prone Rats with Accelerated Hypertension
      Christian T. Abrahamsen, Frank C. Barone, Wallace G. Campbell, Allen H. Nelson, Lisa C. Contino, Mark A. Pullen, Eugene T. Grygielko, Richard M. Edwards, Nicholas J. Laping and David P. Brooks
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 21-28; DOI: https://doi.org/10.1124/jpet.301.1.21
  2. El-Mas, Mahmoud M.

    1. You have access
      Cyclosporine Adversely Affects Baroreflexes via Inhibition of Testosterone Modulation of Cardiac Vagal Control
      Mahmoud M. El-Mas, Elham A. Afify, Amal G. Omar and Fouad M. Sharabi
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 346-354; DOI: https://doi.org/10.1124/jpet.301.1.346
  3. Elfarra, Adnan A.

    1. You have access
      Novel Glutathione-Dependent Thiopurine Prodrugs: Evidence for Enhanced Cytotoxicity in Tumor Cells and for Decreased Bone Marrow Toxicity in Mice
      Sjofn Gunnarsdottir, Marian Rucki and Adnan A. Elfarra
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 77-86; DOI: https://doi.org/10.1124/jpet.301.1.77
  4. Endou, Hitoshi

    1. You have access
      Human Organic Anion Transporters and Human Organic Cation Transporters Mediate Renal Transport of Prostaglandins
      Hiroaki Kimura, Michio Takeda, Shinichi Narikawa, Atsushi Enomoto, Kimiyoshi Ichida and Hitoshi Endou
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 293-298; DOI: https://doi.org/10.1124/jpet.301.1.293
  5. Enomoto, Atsushi

    1. You have access
      Human Organic Anion Transporters and Human Organic Cation Transporters Mediate Renal Transport of Prostaglandins
      Hiroaki Kimura, Michio Takeda, Shinichi Narikawa, Atsushi Enomoto, Kimiyoshi Ichida and Hitoshi Endou
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 293-298; DOI: https://doi.org/10.1124/jpet.301.1.293
  6. e Silva, Patricia M. R.

    1. You have access
      The Selective Phosphodiesterase 4 Inhibitor RP 73-401 Reduced Matrix Metalloproteinase 9 Activity and Transforming Growth Factor-β Release During Acute Lung Injury in Mice: The Role of the Balance Between Tumor Necrosis Factor-α and Interleukin-10
      Marianne Corbel, Noëlla Germain, Jérôme Lanchou, Sophie Molet, Patricia M. R. e Silva, Marco A. Martins, Elisabeth Boichot and Vincent Lagente
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 258-265; DOI: https://doi.org/10.1124/jpet.301.1.258

F

  1. Farrell, Dorothy E.

    1. You have access
      Influence of Porcine Actinobacillus pleuropneumoniae Infection and Dexamethasone on the Pharmacokinetic Parameters of Enrofloxacin
      Lynn O. Post, Carol V. Cope, Dorothy E. Farrell, John D. Baker and Michael J. Myers
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 217-222; DOI: https://doi.org/10.1124/jpet.301.1.217
  2. Feigl, Eric O.

    1. You have access
      Altered Cardiovascular Responses in Mice Lacking the M1 Muscarinic Acetylcholine Receptor
      Sandrine N. Hardouin, Keith N. Richmond, Andrew Zimmerman, Susan E. Hamilton, Eric O. Feigl and Neil M. Nathanson
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 129-137; DOI: https://doi.org/10.1124/jpet.301.1.129
  3. Felipo, Vicente

    1. You have access
      Prevention of in Vivo Excitotoxicity by a Family of Trialkylglycines, a Novel Class of Neuroprotectants
      Carmina Montoliu, Marc Humet, Juan-José Canales, Jozef Burda, Rosa Planells-Cases, Francisco Sánchez-Baeza, Teresa Carbonell, Enrique Pérez-Payá, Angel Messeguer, Antonio Ferrer-Montiel and Vicente Felipo
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 29-36; DOI: https://doi.org/10.1124/jpet.301.1.29
  4. Ferrer-Montiel, Antonio

    1. You have access
      Prevention of in Vivo Excitotoxicity by a Family of Trialkylglycines, a Novel Class of Neuroprotectants
      Carmina Montoliu, Marc Humet, Juan-José Canales, Jozef Burda, Rosa Planells-Cases, Francisco Sánchez-Baeza, Teresa Carbonell, Enrique Pérez-Payá, Angel Messeguer, Antonio Ferrer-Montiel and Vicente Felipo
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 29-36; DOI: https://doi.org/10.1124/jpet.301.1.29
  5. Fischman, Marian W.

    1. You have access
      Intravenous Buprenorphine Self-Administration by Detoxified Heroin Abusers
      Sandra D. Comer, Eric D. Collins and Marian W. Fischman
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 266-276; DOI: https://doi.org/10.1124/jpet.301.1.266
  6. Fisher, A. N.

    1. You have access
      Intranasal Delivery of Morphine
      L. Illum, P. Watts, A. N. Fisher, M. Hinchcliffe, H. Norbury, I. Jabbal-Gill, R. Nankervis and S. S. Davis
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 391-400; DOI: https://doi.org/10.1124/jpet.301.1.391
  7. Flechtner-Mors, M.

    1. You have access
      In Vivo α1-Adrenergic Lipolytic Activity in Subcutaneous Adipose Tissue of Obese Subjects
      M. Flechtner-Mors, C. P. Jenkinson, A. Alt, G. Adler and H. H. Ditschuneit
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 229-233; DOI: https://doi.org/10.1124/jpet.301.1.229
  8. Fontaine, Evelyne

    1. You have access
      4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine Hydrochloride (SSR125543A): A Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. I. Biochemical and Pharmacological Characterization
      Danielle Gully, Michel Geslin, Laurence Serva, Evelyne Fontaine, Pierre Roger, Christine Lair, Valerie Darre, Claudine Marcy, Pierre-Eric Rouby, Jacques Simiand, Josette Guitard, Georgette Gout, Regis Steinberg, Daniel Rodier, Guy Griebel, Philippe Soubrie, Marc Pascal, Rebecca Pruss, Bernard Scatton, Jean-Pierre Maffrand and Gerard Le Fur
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 322-332; DOI: https://doi.org/10.1124/jpet.301.1.322
  9. Forman, Henry Jay

    1. You have access
      Priming of Alveolar Macrophage Respiratory Burst by H2O2 Is Prevented by Phosphatidylcholine-Specific Phospholipase C Inhibitor Tricyclodecan-9-yl-xanthate (D609)
      Julio Girón-Calle, Kousthub Srivatsa and Henry Jay Forman
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 87-94; DOI: https://doi.org/10.1124/jpet.301.1.87
  10. Friedel, Godehard

    1. You have access
      Dose Optimization of a Doxorubicin Prodrug (HMR 1826) in Isolated Perfused Human Lungs: Low Tumor pH Promotes Prodrug Activation by β-Glucuronidase
      Thomas E. Mürdter, Godehard Friedel, Janne T. Backman, Monika McClellan, Monika Schick, Manfred Gerken, Klaus Bosslet, Peter Fritz, Heikki Toomes, Heyo K. Kroemer and Bernhard Sperker
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 223-228; DOI: https://doi.org/10.1124/jpet.301.1.223
  11. Fritz, Peter

    1. You have access
      Dose Optimization of a Doxorubicin Prodrug (HMR 1826) in Isolated Perfused Human Lungs: Low Tumor pH Promotes Prodrug Activation by β-Glucuronidase
      Thomas E. Mürdter, Godehard Friedel, Janne T. Backman, Monika McClellan, Monika Schick, Manfred Gerken, Klaus Bosslet, Peter Fritz, Heikki Toomes, Heyo K. Kroemer and Bernhard Sperker
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 223-228; DOI: https://doi.org/10.1124/jpet.301.1.223
  12. Fujisawa, Reiko

    1. You have access
      β1-Selective Agonist (−)-1-(3,4-Dimethoxyphenetylamino)-3-(3,4-dihydroxy)-2-propanol [(−)-RO363] Differentially Interacts with Key Amino Acids Responsible for β1-Selective Binding in Resting and Active States
      Yoshiyuki Sugimoto, Reiko Fujisawa, Ryuji Tanimura, Anne Laure Lattion, Susanna Cotecchia, Gozoh Tsujimoto, Taku Nagao and Hitoshi Kurose
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 51-58; DOI: https://doi.org/10.1124/jpet.301.1.51
  13. Furtmüller, Roman

    1. You have access
      Tranexamic Acid, a Widely Used Antifibrinolytic Agent, Causes Convulsions by a γ-Aminobutyric AcidA Receptor Antagonistic Effect
      Roman Furtmüller, Michael G. Schlag, Michael Berger, Rudolf Hopf, Sigismund Huck, Werner Sieghart and Heinz Redl
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 168-173; DOI: https://doi.org/10.1124/jpet.301.1.168

G

  1. Gerken, Manfred

    1. You have access
      Dose Optimization of a Doxorubicin Prodrug (HMR 1826) in Isolated Perfused Human Lungs: Low Tumor pH Promotes Prodrug Activation by β-Glucuronidase
      Thomas E. Mürdter, Godehard Friedel, Janne T. Backman, Monika McClellan, Monika Schick, Manfred Gerken, Klaus Bosslet, Peter Fritz, Heikki Toomes, Heyo K. Kroemer and Bernhard Sperker
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 223-228; DOI: https://doi.org/10.1124/jpet.301.1.223
  2. Germain, Noëlla

    1. You have access
      The Selective Phosphodiesterase 4 Inhibitor RP 73-401 Reduced Matrix Metalloproteinase 9 Activity and Transforming Growth Factor-β Release During Acute Lung Injury in Mice: The Role of the Balance Between Tumor Necrosis Factor-α and Interleukin-10
      Marianne Corbel, Noëlla Germain, Jérôme Lanchou, Sophie Molet, Patricia M. R. e Silva, Marco A. Martins, Elisabeth Boichot and Vincent Lagente
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 258-265; DOI: https://doi.org/10.1124/jpet.301.1.258
  3. Geslin, Michel

    1. You have access
      4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine Hydrochloride (SSR125543A): A Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. I. Biochemical and Pharmacological Characterization
      Danielle Gully, Michel Geslin, Laurence Serva, Evelyne Fontaine, Pierre Roger, Christine Lair, Valerie Darre, Claudine Marcy, Pierre-Eric Rouby, Jacques Simiand, Josette Guitard, Georgette Gout, Regis Steinberg, Daniel Rodier, Guy Griebel, Philippe Soubrie, Marc Pascal, Rebecca Pruss, Bernard Scatton, Jean-Pierre Maffrand and Gerard Le Fur
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 322-332; DOI: https://doi.org/10.1124/jpet.301.1.322
    2. You have access
      4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine Hydrochloride (SSR125543A), a Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. II. Characterization in Rodent Models of Stress-Related Disorders
      Guy Griebel, Jacques Simiand, Régis Steinberg, Mireille Jung, Danielle Gully, Pierre Roger, Michel Geslin, Bernard Scatton, Jean-Pierre Maffrand and Philippe Soubrié
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 333-345; DOI: https://doi.org/10.1124/jpet.301.1.333
  4. Girón-Calle, Julio

    1. You have access
      Priming of Alveolar Macrophage Respiratory Burst by H2O2 Is Prevented by Phosphatidylcholine-Specific Phospholipase C Inhibitor Tricyclodecan-9-yl-xanthate (D609)
      Julio Girón-Calle, Kousthub Srivatsa and Henry Jay Forman
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 87-94; DOI: https://doi.org/10.1124/jpet.301.1.87
  5. Gordon, Adrienne S.

    1. You have access
      Ethanol Stimulates cAMP-Responsive Element (CRE)-Mediated Transcription via CRE-Binding Protein and cAMP-Dependent Protein Kinase
      Orna Asher, Thomas D. Cunningham, Lina Yao, Adrienne S. Gordon and Ivan Diamond
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 66-70; DOI: https://doi.org/10.1124/jpet.301.1.66
  6. Gout, Georgette

    1. You have access
      4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine Hydrochloride (SSR125543A): A Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. I. Biochemical and Pharmacological Characterization
      Danielle Gully, Michel Geslin, Laurence Serva, Evelyne Fontaine, Pierre Roger, Christine Lair, Valerie Darre, Claudine Marcy, Pierre-Eric Rouby, Jacques Simiand, Josette Guitard, Georgette Gout, Regis Steinberg, Daniel Rodier, Guy Griebel, Philippe Soubrie, Marc Pascal, Rebecca Pruss, Bernard Scatton, Jean-Pierre Maffrand and Gerard Le Fur
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 322-332; DOI: https://doi.org/10.1124/jpet.301.1.322
  7. Griebel, Guy

    1. You have access
      4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine Hydrochloride (SSR125543A): A Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. I. Biochemical and Pharmacological Characterization
      Danielle Gully, Michel Geslin, Laurence Serva, Evelyne Fontaine, Pierre Roger, Christine Lair, Valerie Darre, Claudine Marcy, Pierre-Eric Rouby, Jacques Simiand, Josette Guitard, Georgette Gout, Regis Steinberg, Daniel Rodier, Guy Griebel, Philippe Soubrie, Marc Pascal, Rebecca Pruss, Bernard Scatton, Jean-Pierre Maffrand and Gerard Le Fur
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 322-332; DOI: https://doi.org/10.1124/jpet.301.1.322
    2. You have access
      4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine Hydrochloride (SSR125543A), a Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. II. Characterization in Rodent Models of Stress-Related Disorders
      Guy Griebel, Jacques Simiand, Régis Steinberg, Mireille Jung, Danielle Gully, Pierre Roger, Michel Geslin, Bernard Scatton, Jean-Pierre Maffrand and Philippe Soubrié
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 333-345; DOI: https://doi.org/10.1124/jpet.301.1.333
  8. Grygielko, Eugene T.

    1. You have access
      The Angiotensin Type 1 Receptor Antagonist, Eprosartan, Attenuates the Progression of Renal Disease in Spontaneously Hypertensive Stroke-Prone Rats with Accelerated Hypertension
      Christian T. Abrahamsen, Frank C. Barone, Wallace G. Campbell, Allen H. Nelson, Lisa C. Contino, Mark A. Pullen, Eugene T. Grygielko, Richard M. Edwards, Nicholas J. Laping and David P. Brooks
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 21-28; DOI: https://doi.org/10.1124/jpet.301.1.21
  9. Gudelsky, Gary A.

    1. You have access
      3,4-Methylenedioxymethamphetamine Produces Glycogenolysis and Increases the Extracellular Concentration of Glucose in the Rat Brain
      Altaf S. Darvesh, Mahalakshmi Shankaran and Gary A. Gudelsky
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 138-144; DOI: https://doi.org/10.1124/jpet.301.1.138
  10. Guitard, Josette

    1. You have access
      4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine Hydrochloride (SSR125543A): A Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. I. Biochemical and Pharmacological Characterization
      Danielle Gully, Michel Geslin, Laurence Serva, Evelyne Fontaine, Pierre Roger, Christine Lair, Valerie Darre, Claudine Marcy, Pierre-Eric Rouby, Jacques Simiand, Josette Guitard, Georgette Gout, Regis Steinberg, Daniel Rodier, Guy Griebel, Philippe Soubrie, Marc Pascal, Rebecca Pruss, Bernard Scatton, Jean-Pierre Maffrand and Gerard Le Fur
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 322-332; DOI: https://doi.org/10.1124/jpet.301.1.322
  11. Gully, Danielle

    1. You have access
      4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine Hydrochloride (SSR125543A): A Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. I. Biochemical and Pharmacological Characterization
      Danielle Gully, Michel Geslin, Laurence Serva, Evelyne Fontaine, Pierre Roger, Christine Lair, Valerie Darre, Claudine Marcy, Pierre-Eric Rouby, Jacques Simiand, Josette Guitard, Georgette Gout, Regis Steinberg, Daniel Rodier, Guy Griebel, Philippe Soubrie, Marc Pascal, Rebecca Pruss, Bernard Scatton, Jean-Pierre Maffrand and Gerard Le Fur
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 322-332; DOI: https://doi.org/10.1124/jpet.301.1.322
    2. You have access
      4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine Hydrochloride (SSR125543A), a Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. II. Characterization in Rodent Models of Stress-Related Disorders
      Guy Griebel, Jacques Simiand, Régis Steinberg, Mireille Jung, Danielle Gully, Pierre Roger, Michel Geslin, Bernard Scatton, Jean-Pierre Maffrand and Philippe Soubrié
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 333-345; DOI: https://doi.org/10.1124/jpet.301.1.333
  12. Gunnarsdottir, Sjofn

    1. You have access
      Novel Glutathione-Dependent Thiopurine Prodrugs: Evidence for Enhanced Cytotoxicity in Tumor Cells and for Decreased Bone Marrow Toxicity in Mice
      Sjofn Gunnarsdottir, Marian Rucki and Adnan A. Elfarra
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 77-86; DOI: https://doi.org/10.1124/jpet.301.1.77
  13. Gupte, Sachin A.

    1. You have access
      Inhibitors of Pentose Phosphate Pathway Cause Vasodilation: Involvement of Voltage-Gated Potassium Channels
      Sachin A. Gupte, Kai-Xun Li, Takao Okada, Koichi Sato and Masahiko Oka
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 299-305; DOI: https://doi.org/10.1124/jpet.301.1.299

H

  1. Hamilton, Susan E.

    1. You have access
      Altered Cardiovascular Responses in Mice Lacking the M1 Muscarinic Acetylcholine Receptor
      Sandrine N. Hardouin, Keith N. Richmond, Andrew Zimmerman, Susan E. Hamilton, Eric O. Feigl and Neil M. Nathanson
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 129-137; DOI: https://doi.org/10.1124/jpet.301.1.129
  2. Hardouin, Sandrine N.

    1. You have access
      Altered Cardiovascular Responses in Mice Lacking the M1 Muscarinic Acetylcholine Receptor
      Sandrine N. Hardouin, Keith N. Richmond, Andrew Zimmerman, Susan E. Hamilton, Eric O. Feigl and Neil M. Nathanson
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 129-137; DOI: https://doi.org/10.1124/jpet.301.1.129
  3. Hartley, Dylan P.

    1. You have access
      Gender-Specific and Developmental Influences on the Expression of Rat Organic Anion Transporters
      Susan C. N. Buist, Nathan J. Cherrington, Supratim Choudhuri, Dylan P. Hartley and Curtis D. Klaassen
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 145-151; DOI: https://doi.org/10.1124/jpet.301.1.145
  4. Haskó, György

    1. You have access
      Inhibitors of ATP-Binding Cassette Transporters Suppress Interleukin-12 p40 Production and Major Histocompatibility Complex II Up-Regulation in Macrophages
      György Haskó, Edwin A. Deitch, Zoltán H. Németh, David G. Kuhel and Csaba Szabó
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 103-110; DOI: https://doi.org/10.1124/jpet.301.1.103
  5. Heinroth-Hoffmann, Ingrid

    1. You have access
      Differential Effects of Bucindolol and Carvedilol on Noradenaline-Induced Hypertrophic Response in Ventricular Cardiomyocytes of Adult Rats
      Klaus Pönicke, Ingrid Heinroth-Hoffmann and Otto-Erich Brodde
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 71-76; DOI: https://doi.org/10.1124/jpet.301.1.71
  6. Hersperger, Rene

    1. You have access
      Pharmacological Profile of a Novel Phosphodiesterase 4 Inhibitor, 4-(8-Benzo[1,2,5]oxadiazol-5-yl-[1,7]naphthyridin-6-yl)-benzoic Acid (NVP-ABE171), a 1,7-Naphthyridine Derivative, with Anti-Inflammatory Activities
      Alexandre Trifilieff, Daniel Wyss, Christoph Walker, Lazzaro Mazzoni and Rene Hersperger
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 241-248; DOI: https://doi.org/10.1124/jpet.301.1.241
  7. Hinchcliffe, M.

    1. You have access
      Intranasal Delivery of Morphine
      L. Illum, P. Watts, A. N. Fisher, M. Hinchcliffe, H. Norbury, I. Jabbal-Gill, R. Nankervis and S. S. Davis
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 391-400; DOI: https://doi.org/10.1124/jpet.301.1.391
  8. Hocart, Simon J.

    1. You have access
      Elucidation of Vasoactive Intestinal Peptide Pharmacophore for VPAC1 Receptors in Human, Rat, and Guinea Pig
      Hisato Igarashi, Tetsuhide Ito, Wei Hou, Samuel A. Mantey, Tapas K. Pradhan, Charles D. Ulrich, Simon J. Hocart, David H. Coy and Robert T. Jensen
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 37-50; DOI: https://doi.org/10.1124/jpet.301.1.37
  9. Hollenberg, Paul F.

    1. You have access
      Mechanism-Based Inactivation of Cytochrome P450 3A4 by 17α-Ethynylestradiol: Evidence for Heme Destruction and Covalent Binding to Protein
      Hsia-lien Lin, Ute M. Kent and Paul F. Hollenberg
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 160-167; DOI: https://doi.org/10.1124/jpet.301.1.160
  10. Hong, Ki Whan

    1. You have access
      Neuroprotective Effect of (2S,3S,4R)-N"-cyano-N-(6-amino-3, 4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2H-benzopyran-4-yl)-N′-benzylguanidine (KR-31378), a Benzopyran Analog, against Focal Ischemic Brain Damage in Rats
      Ki Whan Hong, Ki Young Kim, Jeong Hyun Lee, Hwa Kyoung Shin, Yong Geun Kwak, Sun-Ok Kim, Hong Lim and Sung-Eun Yoo
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 210-216; DOI: https://doi.org/10.1124/jpet.301.1.210
  11. Hopf, Rudolf

    1. You have access
      Tranexamic Acid, a Widely Used Antifibrinolytic Agent, Causes Convulsions by a γ-Aminobutyric AcidA Receptor Antagonistic Effect
      Roman Furtmüller, Michael G. Schlag, Michael Berger, Rudolf Hopf, Sigismund Huck, Werner Sieghart and Heinz Redl
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 168-173; DOI: https://doi.org/10.1124/jpet.301.1.168
  12. Hou, Wei

    1. You have access
      Elucidation of Vasoactive Intestinal Peptide Pharmacophore for VPAC1 Receptors in Human, Rat, and Guinea Pig
      Hisato Igarashi, Tetsuhide Ito, Wei Hou, Samuel A. Mantey, Tapas K. Pradhan, Charles D. Ulrich, Simon J. Hocart, David H. Coy and Robert T. Jensen
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 37-50; DOI: https://doi.org/10.1124/jpet.301.1.37
  13. Huck, Sigismund

    1. You have access
      Tranexamic Acid, a Widely Used Antifibrinolytic Agent, Causes Convulsions by a γ-Aminobutyric AcidA Receptor Antagonistic Effect
      Roman Furtmüller, Michael G. Schlag, Michael Berger, Rudolf Hopf, Sigismund Huck, Werner Sieghart and Heinz Redl
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 168-173; DOI: https://doi.org/10.1124/jpet.301.1.168
  14. Humet, Marc

    1. You have access
      Prevention of in Vivo Excitotoxicity by a Family of Trialkylglycines, a Novel Class of Neuroprotectants
      Carmina Montoliu, Marc Humet, Juan-José Canales, Jozef Burda, Rosa Planells-Cases, Francisco Sánchez-Baeza, Teresa Carbonell, Enrique Pérez-Payá, Angel Messeguer, Antonio Ferrer-Montiel and Vicente Felipo
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 29-36; DOI: https://doi.org/10.1124/jpet.301.1.29

I

  1. Ichida, Kimiyoshi

    1. You have access
      Human Organic Anion Transporters and Human Organic Cation Transporters Mediate Renal Transport of Prostaglandins
      Hiroaki Kimura, Michio Takeda, Shinichi Narikawa, Atsushi Enomoto, Kimiyoshi Ichida and Hitoshi Endou
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 293-298; DOI: https://doi.org/10.1124/jpet.301.1.293
  2. Igarashi, Hisato

    1. You have access
      Elucidation of Vasoactive Intestinal Peptide Pharmacophore for VPAC1 Receptors in Human, Rat, and Guinea Pig
      Hisato Igarashi, Tetsuhide Ito, Wei Hou, Samuel A. Mantey, Tapas K. Pradhan, Charles D. Ulrich, Simon J. Hocart, David H. Coy and Robert T. Jensen
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 37-50; DOI: https://doi.org/10.1124/jpet.301.1.37
  3. Iida, Hirokazu

    1. You have access
      Activation of Endogenous Nitric Oxide Synthase Coupled with Methacholine-Induced Exocytosis in Rat Parotid Acinar Cells
      Yasuko Ishikawa, Hirokazu Iida, Mariusz T. Skowronski and Hajime Ishida
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 355-363; DOI: https://doi.org/10.1124/jpet.301.1.355
  4. Illum, L.

    1. You have access
      Intranasal Delivery of Morphine
      L. Illum, P. Watts, A. N. Fisher, M. Hinchcliffe, H. Norbury, I. Jabbal-Gill, R. Nankervis and S. S. Davis
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 391-400; DOI: https://doi.org/10.1124/jpet.301.1.391
  5. Ishida, Hajime

    1. You have access
      Activation of Endogenous Nitric Oxide Synthase Coupled with Methacholine-Induced Exocytosis in Rat Parotid Acinar Cells
      Yasuko Ishikawa, Hirokazu Iida, Mariusz T. Skowronski and Hajime Ishida
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 355-363; DOI: https://doi.org/10.1124/jpet.301.1.355
  6. Ishikawa, Yasuko

    1. You have access
      Activation of Endogenous Nitric Oxide Synthase Coupled with Methacholine-Induced Exocytosis in Rat Parotid Acinar Cells
      Yasuko Ishikawa, Hirokazu Iida, Mariusz T. Skowronski and Hajime Ishida
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 355-363; DOI: https://doi.org/10.1124/jpet.301.1.355
  7. Ito, Tetsuhide

    1. You have access
      Elucidation of Vasoactive Intestinal Peptide Pharmacophore for VPAC1 Receptors in Human, Rat, and Guinea Pig
      Hisato Igarashi, Tetsuhide Ito, Wei Hou, Samuel A. Mantey, Tapas K. Pradhan, Charles D. Ulrich, Simon J. Hocart, David H. Coy and Robert T. Jensen
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 37-50; DOI: https://doi.org/10.1124/jpet.301.1.37
  8. Itoh, Toshiyuki

    1. You have access
      New Cytokine Delivery System Using Gelatin Microspheres Containing Interleukin-10 for Experimental Inflammatory Bowel Disease
      Hiroshi Nakase, Kazuichi Okazaki, Yasuhiko Tabata, Makoto Ozeki, Norihiko Watanabe, Masaya Ohana, Suguru Uose, Kazushige Uchida, Toshiki Nishi, Minoru Mastuura, Hiroyuki Tamaki, Toshiyuki Itoh, Chiharu Kawanami and Tsutomu Chiba
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 59-65; DOI: https://doi.org/10.1124/jpet.301.1.59

J

  1. Jabbal-Gill, I.

    1. You have access
      Intranasal Delivery of Morphine
      L. Illum, P. Watts, A. N. Fisher, M. Hinchcliffe, H. Norbury, I. Jabbal-Gill, R. Nankervis and S. S. Davis
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 391-400; DOI: https://doi.org/10.1124/jpet.301.1.391
  2. Jenkinson, C. P.

    1. You have access
      In Vivo α1-Adrenergic Lipolytic Activity in Subcutaneous Adipose Tissue of Obese Subjects
      M. Flechtner-Mors, C. P. Jenkinson, A. Alt, G. Adler and H. H. Ditschuneit
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 229-233; DOI: https://doi.org/10.1124/jpet.301.1.229
  3. Jensen, Robert T.

    1. You have access
      Elucidation of Vasoactive Intestinal Peptide Pharmacophore for VPAC1 Receptors in Human, Rat, and Guinea Pig
      Hisato Igarashi, Tetsuhide Ito, Wei Hou, Samuel A. Mantey, Tapas K. Pradhan, Charles D. Ulrich, Simon J. Hocart, David H. Coy and Robert T. Jensen
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 37-50; DOI: https://doi.org/10.1124/jpet.301.1.37
  4. Ju, Haisong

    1. You have access
      Sustained Activation of p38 Mitogen-Activated Protein Kinase Contributes to the Vascular Response to Injury
      Haisong Ju, Sandhya Nerurkar, Charles F. Sauermelch, Alan R. Olzinski, Rosanna Mirabile, Dawn Zimmerman, John C. Lee, Jerry Adams, Joseph Sisko, Marinella Berova and Robert N. Willette
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 15-20; DOI: https://doi.org/10.1124/jpet.301.1.15
  5. Jung, Mireille

    1. You have access
      4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine Hydrochloride (SSR125543A), a Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. II. Characterization in Rodent Models of Stress-Related Disorders
      Guy Griebel, Jacques Simiand, Régis Steinberg, Mireille Jung, Danielle Gully, Pierre Roger, Michel Geslin, Bernard Scatton, Jean-Pierre Maffrand and Philippe Soubrié
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 333-345; DOI: https://doi.org/10.1124/jpet.301.1.333
  6. Junien, Jean-Louis

    1. You have access
      Pharmacological Profile of a New, Potent, and Long-Acting Gonadotropin-Releasing Hormone Antagonist: Degarelix
      Pierre Broqua, Pierre J.-M. Riviere, P. Michael Conn, Jean E. Rivier, Michel L. Aubert and Jean-Louis Junien
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 95-102; DOI: https://doi.org/10.1124/jpet.301.1.95

K

  1. Kawanami, Chiharu

    1. You have access
      New Cytokine Delivery System Using Gelatin Microspheres Containing Interleukin-10 for Experimental Inflammatory Bowel Disease
      Hiroshi Nakase, Kazuichi Okazaki, Yasuhiko Tabata, Makoto Ozeki, Norihiko Watanabe, Masaya Ohana, Suguru Uose, Kazushige Uchida, Toshiki Nishi, Minoru Mastuura, Hiroyuki Tamaki, Toshiyuki Itoh, Chiharu Kawanami and Tsutomu Chiba
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 59-65; DOI: https://doi.org/10.1124/jpet.301.1.59
  2. Kehrer, James P.

    1. You have access
      In Utero Ethanol Suppresses Cerebellar Activator Protein-1 and Nuclear Factor-κB Transcriptional Activation in a Rat Fetal Alcohol Syndrome Model
      George K. Acquaah-Mensah, James P. Kehrer and Steven W. Leslie
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 277-283; DOI: https://doi.org/10.1124/jpet.301.1.277
  3. Kent, Ute M.

    1. You have access
      Mechanism-Based Inactivation of Cytochrome P450 3A4 by 17α-Ethynylestradiol: Evidence for Heme Destruction and Covalent Binding to Protein
      Hsia-lien Lin, Ute M. Kent and Paul F. Hollenberg
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 160-167; DOI: https://doi.org/10.1124/jpet.301.1.160
  4. Kikuchi, Tetsuro

    1. You have access
      Attenuation of Scopolamine-Induced and Age-Associated Memory Impairments by the Sigma and 5-Hydroxytryptamine1A Receptor Agonist OPC-14523 (1-{3-[4-(3-chlorophenyl)-1-piperazinyl]propyl}-5-methoxy-3,4-dihydro-2[1H]-quinolinone monomethanesulfonate)
      Katsura Tottori, Masami Nakai, Yasufumi Uwahodo, Takashi Miwa, Sakiko Yamada, Yasuo Oshiro, Tetsuro Kikuchi and C. Anthony Altar
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 249-257; DOI: https://doi.org/10.1124/jpet.301.1.249
  5. Kim, Ki Young

    1. You have access
      Neuroprotective Effect of (2S,3S,4R)-N"-cyano-N-(6-amino-3, 4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2H-benzopyran-4-yl)-N′-benzylguanidine (KR-31378), a Benzopyran Analog, against Focal Ischemic Brain Damage in Rats
      Ki Whan Hong, Ki Young Kim, Jeong Hyun Lee, Hwa Kyoung Shin, Yong Geun Kwak, Sun-Ok Kim, Hong Lim and Sung-Eun Yoo
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 210-216; DOI: https://doi.org/10.1124/jpet.301.1.210
  6. Kim, Sun-Ok

    1. You have access
      Neuroprotective Effect of (2S,3S,4R)-N"-cyano-N-(6-amino-3, 4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2H-benzopyran-4-yl)-N′-benzylguanidine (KR-31378), a Benzopyran Analog, against Focal Ischemic Brain Damage in Rats
      Ki Whan Hong, Ki Young Kim, Jeong Hyun Lee, Hwa Kyoung Shin, Yong Geun Kwak, Sun-Ok Kim, Hong Lim and Sung-Eun Yoo
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 210-216; DOI: https://doi.org/10.1124/jpet.301.1.210
  7. Kimura, Hiroaki

    1. You have access
      Human Organic Anion Transporters and Human Organic Cation Transporters Mediate Renal Transport of Prostaglandins
      Hiroaki Kimura, Michio Takeda, Shinichi Narikawa, Atsushi Enomoto, Kimiyoshi Ichida and Hitoshi Endou
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 293-298; DOI: https://doi.org/10.1124/jpet.301.1.293
  8. Klaassen, Curtis D.

    1. You have access
      Gender-Specific and Developmental Influences on the Expression of Rat Organic Anion Transporters
      Susan C. N. Buist, Nathan J. Cherrington, Supratim Choudhuri, Dylan P. Hartley and Curtis D. Klaassen
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 145-151; DOI: https://doi.org/10.1124/jpet.301.1.145
  9. Kroemer, Heyo K.

    1. You have access
      Dose Optimization of a Doxorubicin Prodrug (HMR 1826) in Isolated Perfused Human Lungs: Low Tumor pH Promotes Prodrug Activation by β-Glucuronidase
      Thomas E. Mürdter, Godehard Friedel, Janne T. Backman, Monika McClellan, Monika Schick, Manfred Gerken, Klaus Bosslet, Peter Fritz, Heikki Toomes, Heyo K. Kroemer and Bernhard Sperker
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 223-228; DOI: https://doi.org/10.1124/jpet.301.1.223
  10. Kuhel, David G.

    1. You have access
      Inhibitors of ATP-Binding Cassette Transporters Suppress Interleukin-12 p40 Production and Major Histocompatibility Complex II Up-Regulation in Macrophages
      György Haskó, Edwin A. Deitch, Zoltán H. Németh, David G. Kuhel and Csaba Szabó
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 103-110; DOI: https://doi.org/10.1124/jpet.301.1.103
  11. Kurose, Hitoshi

    1. You have access
      β1-Selective Agonist (−)-1-(3,4-Dimethoxyphenetylamino)-3-(3,4-dihydroxy)-2-propanol [(−)-RO363] Differentially Interacts with Key Amino Acids Responsible for β1-Selective Binding in Resting and Active States
      Yoshiyuki Sugimoto, Reiko Fujisawa, Ryuji Tanimura, Anne Laure Lattion, Susanna Cotecchia, Gozoh Tsujimoto, Taku Nagao and Hitoshi Kurose
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 51-58; DOI: https://doi.org/10.1124/jpet.301.1.51
  12. Kwak, Yong Geun

    1. You have access
      Neuroprotective Effect of (2S,3S,4R)-N"-cyano-N-(6-amino-3, 4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2H-benzopyran-4-yl)-N′-benzylguanidine (KR-31378), a Benzopyran Analog, against Focal Ischemic Brain Damage in Rats
      Ki Whan Hong, Ki Young Kim, Jeong Hyun Lee, Hwa Kyoung Shin, Yong Geun Kwak, Sun-Ok Kim, Hong Lim and Sung-Eun Yoo
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 210-216; DOI: https://doi.org/10.1124/jpet.301.1.210

L

  1. Lagente, Vincent

    1. You have access
      The Selective Phosphodiesterase 4 Inhibitor RP 73-401 Reduced Matrix Metalloproteinase 9 Activity and Transforming Growth Factor-β Release During Acute Lung Injury in Mice: The Role of the Balance Between Tumor Necrosis Factor-α and Interleukin-10
      Marianne Corbel, Noëlla Germain, Jérôme Lanchou, Sophie Molet, Patricia M. R. e Silva, Marco A. Martins, Elisabeth Boichot and Vincent Lagente
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 258-265; DOI: https://doi.org/10.1124/jpet.301.1.258
  2. Lair, Christine

    1. You have access
      4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine Hydrochloride (SSR125543A): A Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. I. Biochemical and Pharmacological Characterization
      Danielle Gully, Michel Geslin, Laurence Serva, Evelyne Fontaine, Pierre Roger, Christine Lair, Valerie Darre, Claudine Marcy, Pierre-Eric Rouby, Jacques Simiand, Josette Guitard, Georgette Gout, Regis Steinberg, Daniel Rodier, Guy Griebel, Philippe Soubrie, Marc Pascal, Rebecca Pruss, Bernard Scatton, Jean-Pierre Maffrand and Gerard Le Fur
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 322-332; DOI: https://doi.org/10.1124/jpet.301.1.322
  3. Lanchou, Jérôme

    1. You have access
      The Selective Phosphodiesterase 4 Inhibitor RP 73-401 Reduced Matrix Metalloproteinase 9 Activity and Transforming Growth Factor-β Release During Acute Lung Injury in Mice: The Role of the Balance Between Tumor Necrosis Factor-α and Interleukin-10
      Marianne Corbel, Noëlla Germain, Jérôme Lanchou, Sophie Molet, Patricia M. R. e Silva, Marco A. Martins, Elisabeth Boichot and Vincent Lagente
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 258-265; DOI: https://doi.org/10.1124/jpet.301.1.258
  4. Laping, Nicholas J.

    1. You have access
      The Angiotensin Type 1 Receptor Antagonist, Eprosartan, Attenuates the Progression of Renal Disease in Spontaneously Hypertensive Stroke-Prone Rats with Accelerated Hypertension
      Christian T. Abrahamsen, Frank C. Barone, Wallace G. Campbell, Allen H. Nelson, Lisa C. Contino, Mark A. Pullen, Eugene T. Grygielko, Richard M. Edwards, Nicholas J. Laping and David P. Brooks
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 21-28; DOI: https://doi.org/10.1124/jpet.301.1.21
  5. Lattion, Anne Laure

    1. You have access
      β1-Selective Agonist (−)-1-(3,4-Dimethoxyphenetylamino)-3-(3,4-dihydroxy)-2-propanol [(−)-RO363] Differentially Interacts with Key Amino Acids Responsible for β1-Selective Binding in Resting and Active States
      Yoshiyuki Sugimoto, Reiko Fujisawa, Ryuji Tanimura, Anne Laure Lattion, Susanna Cotecchia, Gozoh Tsujimoto, Taku Nagao and Hitoshi Kurose
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 51-58; DOI: https://doi.org/10.1124/jpet.301.1.51
  6. Lee, Jeong Hyun

    1. You have access
      Neuroprotective Effect of (2S,3S,4R)-N"-cyano-N-(6-amino-3, 4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2H-benzopyran-4-yl)-N′-benzylguanidine (KR-31378), a Benzopyran Analog, against Focal Ischemic Brain Damage in Rats
      Ki Whan Hong, Ki Young Kim, Jeong Hyun Lee, Hwa Kyoung Shin, Yong Geun Kwak, Sun-Ok Kim, Hong Lim and Sung-Eun Yoo
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 210-216; DOI: https://doi.org/10.1124/jpet.301.1.210
  7. Lee, John C.

    1. You have access
      Sustained Activation of p38 Mitogen-Activated Protein Kinase Contributes to the Vascular Response to Injury
      Haisong Ju, Sandhya Nerurkar, Charles F. Sauermelch, Alan R. Olzinski, Rosanna Mirabile, Dawn Zimmerman, John C. Lee, Jerry Adams, Joseph Sisko, Marinella Berova and Robert N. Willette
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 15-20; DOI: https://doi.org/10.1124/jpet.301.1.15
  8. Lee, Tsung-Ming

    1. You have access
      Differential Effects of Sarcolemmal and Mitochondrial KATP Channels Activated by 17β-Estradiol on Reperfusion Arrhythmias and Infarct Sizes in Canine Hearts
      Chang-Her Tsai, Sheng-Fang Su, Tsai-Fwu Chou and Tsung-Ming Lee
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 234-240; DOI: https://doi.org/10.1124/jpet.301.1.234
  9. Le Fur, Gerard

    1. You have access
      4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine Hydrochloride (SSR125543A): A Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. I. Biochemical and Pharmacological Characterization
      Danielle Gully, Michel Geslin, Laurence Serva, Evelyne Fontaine, Pierre Roger, Christine Lair, Valerie Darre, Claudine Marcy, Pierre-Eric Rouby, Jacques Simiand, Josette Guitard, Georgette Gout, Regis Steinberg, Daniel Rodier, Guy Griebel, Philippe Soubrie, Marc Pascal, Rebecca Pruss, Bernard Scatton, Jean-Pierre Maffrand and Gerard Le Fur
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 322-332; DOI: https://doi.org/10.1124/jpet.301.1.322
  10. Leslie, Steven W.

    1. You have access
      In Utero Ethanol Suppresses Cerebellar Activator Protein-1 and Nuclear Factor-κB Transcriptional Activation in a Rat Fetal Alcohol Syndrome Model
      George K. Acquaah-Mensah, James P. Kehrer and Steven W. Leslie
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 277-283; DOI: https://doi.org/10.1124/jpet.301.1.277
  11. Leung, Louis Y.

    1. You have access
      Identification of a Novel Route of Extraction of Sirolimus in Human Small Intestine: Roles of Metabolism and Secretion
      Mary F. Paine, Louis Y. Leung, H. K. Lim, Kecheng Liao, Aram Oganesian, Mei-Yi Zhang, Kenneth E. Thummel and Paul B. Watkins
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 174-186; DOI: https://doi.org/10.1124/jpet.301.1.174
  12. Li, Kai-Xun

    1. You have access
      Inhibitors of Pentose Phosphate Pathway Cause Vasodilation: Involvement of Voltage-Gated Potassium Channels
      Sachin A. Gupte, Kai-Xun Li, Takao Okada, Koichi Sato and Masahiko Oka
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 299-305; DOI: https://doi.org/10.1124/jpet.301.1.299
  13. Liao, Kecheng

    1. You have access
      Identification of a Novel Route of Extraction of Sirolimus in Human Small Intestine: Roles of Metabolism and Secretion
      Mary F. Paine, Louis Y. Leung, H. K. Lim, Kecheng Liao, Aram Oganesian, Mei-Yi Zhang, Kenneth E. Thummel and Paul B. Watkins
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 174-186; DOI: https://doi.org/10.1124/jpet.301.1.174
  14. Lim, H. K.

    1. You have access
      Identification of a Novel Route of Extraction of Sirolimus in Human Small Intestine: Roles of Metabolism and Secretion
      Mary F. Paine, Louis Y. Leung, H. K. Lim, Kecheng Liao, Aram Oganesian, Mei-Yi Zhang, Kenneth E. Thummel and Paul B. Watkins
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 174-186; DOI: https://doi.org/10.1124/jpet.301.1.174
  15. Lim, Hong

    1. You have access
      Neuroprotective Effect of (2S,3S,4R)-N"-cyano-N-(6-amino-3, 4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2H-benzopyran-4-yl)-N′-benzylguanidine (KR-31378), a Benzopyran Analog, against Focal Ischemic Brain Damage in Rats
      Ki Whan Hong, Ki Young Kim, Jeong Hyun Lee, Hwa Kyoung Shin, Yong Geun Kwak, Sun-Ok Kim, Hong Lim and Sung-Eun Yoo
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 210-216; DOI: https://doi.org/10.1124/jpet.301.1.210
  16. Lin, Hsia-lien

    1. You have access
      Mechanism-Based Inactivation of Cytochrome P450 3A4 by 17α-Ethynylestradiol: Evidence for Heme Destruction and Covalent Binding to Protein
      Hsia-lien Lin, Ute M. Kent and Paul F. Hollenberg
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 160-167; DOI: https://doi.org/10.1124/jpet.301.1.160
  17. Löscher, Wolfgang

    1. You have access
      Role of Multidrug Transporters in Pharmacoresistance to Antiepileptic Drugs
      Wolfgang Löscher and Heidrun Potschka
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 7-14; DOI: https://doi.org/10.1124/jpet.301.1.7

M

  1. Maffrand, Jean-Pierre

    1. You have access
      4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine Hydrochloride (SSR125543A): A Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. I. Biochemical and Pharmacological Characterization
      Danielle Gully, Michel Geslin, Laurence Serva, Evelyne Fontaine, Pierre Roger, Christine Lair, Valerie Darre, Claudine Marcy, Pierre-Eric Rouby, Jacques Simiand, Josette Guitard, Georgette Gout, Regis Steinberg, Daniel Rodier, Guy Griebel, Philippe Soubrie, Marc Pascal, Rebecca Pruss, Bernard Scatton, Jean-Pierre Maffrand and Gerard Le Fur
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 322-332; DOI: https://doi.org/10.1124/jpet.301.1.322
    2. You have access
      4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine Hydrochloride (SSR125543A), a Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. II. Characterization in Rodent Models of Stress-Related Disorders
      Guy Griebel, Jacques Simiand, Régis Steinberg, Mireille Jung, Danielle Gully, Pierre Roger, Michel Geslin, Bernard Scatton, Jean-Pierre Maffrand and Philippe Soubrié
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 333-345; DOI: https://doi.org/10.1124/jpet.301.1.333
  2. Mantey, Samuel A.

    1. You have access
      Elucidation of Vasoactive Intestinal Peptide Pharmacophore for VPAC1 Receptors in Human, Rat, and Guinea Pig
      Hisato Igarashi, Tetsuhide Ito, Wei Hou, Samuel A. Mantey, Tapas K. Pradhan, Charles D. Ulrich, Simon J. Hocart, David H. Coy and Robert T. Jensen
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 37-50; DOI: https://doi.org/10.1124/jpet.301.1.37
  3. Marcy, Claudine

    1. You have access
      4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine Hydrochloride (SSR125543A): A Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. I. Biochemical and Pharmacological Characterization
      Danielle Gully, Michel Geslin, Laurence Serva, Evelyne Fontaine, Pierre Roger, Christine Lair, Valerie Darre, Claudine Marcy, Pierre-Eric Rouby, Jacques Simiand, Josette Guitard, Georgette Gout, Regis Steinberg, Daniel Rodier, Guy Griebel, Philippe Soubrie, Marc Pascal, Rebecca Pruss, Bernard Scatton, Jean-Pierre Maffrand and Gerard Le Fur
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 322-332; DOI: https://doi.org/10.1124/jpet.301.1.322
  4. Marı́, Montserrat

    1. You have access
      Adenovirus-Mediated Overexpression of Catalase in the Cytosolic or Mitochondrial Compartment Protects against Toxicity Caused by Glutathione Depletion in HepG2 Cells Expressing CYP2E1
      Montserrat Marı́, Jingxiang Bai and Arthur I. Cederbaum
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 111-118; DOI: https://doi.org/10.1124/jpet.301.1.111
  5. Marien, Marc

    1. You have access
      Effects of Acute and Subchronic Administration of Dexefaroxan, an α2-Adrenoceptor Antagonist, on Memory Performance in Young Adult and Aged Rodents
      Philippe Chopin, Francis C. Colpaert and Marc Marien
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 187-196; DOI: https://doi.org/10.1124/jpet.301.1.187
  6. Martins, Marco A.

    1. You have access
      The Selective Phosphodiesterase 4 Inhibitor RP 73-401 Reduced Matrix Metalloproteinase 9 Activity and Transforming Growth Factor-β Release During Acute Lung Injury in Mice: The Role of the Balance Between Tumor Necrosis Factor-α and Interleukin-10
      Marianne Corbel, Noëlla Germain, Jérôme Lanchou, Sophie Molet, Patricia M. R. e Silva, Marco A. Martins, Elisabeth Boichot and Vincent Lagente
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 258-265; DOI: https://doi.org/10.1124/jpet.301.1.258
  7. Mastuura, Minoru

    1. You have access
      New Cytokine Delivery System Using Gelatin Microspheres Containing Interleukin-10 for Experimental Inflammatory Bowel Disease
      Hiroshi Nakase, Kazuichi Okazaki, Yasuhiko Tabata, Makoto Ozeki, Norihiko Watanabe, Masaya Ohana, Suguru Uose, Kazushige Uchida, Toshiki Nishi, Minoru Mastuura, Hiroyuki Tamaki, Toshiyuki Itoh, Chiharu Kawanami and Tsutomu Chiba
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 59-65; DOI: https://doi.org/10.1124/jpet.301.1.59
  8. Mazzoni, Lazzaro

    1. You have access
      Pharmacological Profile of a Novel Phosphodiesterase 4 Inhibitor, 4-(8-Benzo[1,2,5]oxadiazol-5-yl-[1,7]naphthyridin-6-yl)-benzoic Acid (NVP-ABE171), a 1,7-Naphthyridine Derivative, with Anti-Inflammatory Activities
      Alexandre Trifilieff, Daniel Wyss, Christoph Walker, Lazzaro Mazzoni and Rene Hersperger
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 241-248; DOI: https://doi.org/10.1124/jpet.301.1.241
  9. McClellan, Monika

    1. You have access
      Dose Optimization of a Doxorubicin Prodrug (HMR 1826) in Isolated Perfused Human Lungs: Low Tumor pH Promotes Prodrug Activation by β-Glucuronidase
      Thomas E. Mürdter, Godehard Friedel, Janne T. Backman, Monika McClellan, Monika Schick, Manfred Gerken, Klaus Bosslet, Peter Fritz, Heikki Toomes, Heyo K. Kroemer and Bernhard Sperker
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 223-228; DOI: https://doi.org/10.1124/jpet.301.1.223
  10. Meleg-Smith, Suzanne

    1. You have access
      Cardiovascular Responses Elicited by the “Binge” Administration of Methamphetamine
      Kurt J. Varner, Brian A. Ogden, Joseph Delcarpio and Suzanne Meleg-Smith
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 152-159; DOI: https://doi.org/10.1124/jpet.301.1.152
  11. Menzaghi, F.

    1. You have access
      Effects of (±)-4-{[2-(1-Methyl-2-pyrrolidinyl)ethyl]thio}phenol Hydrochloride (SIB-1553A), a Selective Ligand for Nicotinic Acetylcholine Receptors, in Tests of Visual Attention and Distractibility in Rats and Monkeys
      A. V. Terry, V. B. Risbrough, J. J. Buccafusco and F. Menzaghi
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 284-292; DOI: https://doi.org/10.1124/jpet.301.1.284
  12. Messeguer, Angel

    1. You have access
      Prevention of in Vivo Excitotoxicity by a Family of Trialkylglycines, a Novel Class of Neuroprotectants
      Carmina Montoliu, Marc Humet, Juan-José Canales, Jozef Burda, Rosa Planells-Cases, Francisco Sánchez-Baeza, Teresa Carbonell, Enrique Pérez-Payá, Angel Messeguer, Antonio Ferrer-Montiel and Vicente Felipo
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 29-36; DOI: https://doi.org/10.1124/jpet.301.1.29
  13. Mignon, Laurence

    1. You have access
      Alterations in Responses of Ventral Pallidal Neurons to Excitatory Amino Acids after Long-Term Dopamine Depletion
      Michael S. Turner, Laurence Mignon and T. Celeste Napier
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 371-381; DOI: https://doi.org/10.1124/jpet.301.1.371
  14. Mirabile, Rosanna

    1. You have access
      Sustained Activation of p38 Mitogen-Activated Protein Kinase Contributes to the Vascular Response to Injury
      Haisong Ju, Sandhya Nerurkar, Charles F. Sauermelch, Alan R. Olzinski, Rosanna Mirabile, Dawn Zimmerman, John C. Lee, Jerry Adams, Joseph Sisko, Marinella Berova and Robert N. Willette
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 15-20; DOI: https://doi.org/10.1124/jpet.301.1.15
  15. Miwa, Takashi

    1. You have access
      Attenuation of Scopolamine-Induced and Age-Associated Memory Impairments by the Sigma and 5-Hydroxytryptamine1A Receptor Agonist OPC-14523 (1-{3-[4-(3-chlorophenyl)-1-piperazinyl]propyl}-5-methoxy-3,4-dihydro-2[1H]-quinolinone monomethanesulfonate)
      Katsura Tottori, Masami Nakai, Yasufumi Uwahodo, Takashi Miwa, Sakiko Yamada, Yasuo Oshiro, Tetsuro Kikuchi and C. Anthony Altar
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 249-257; DOI: https://doi.org/10.1124/jpet.301.1.249
  16. Mody, Rupal M.

    1. You have access
      ς2-Receptor Regulation of Dopamine Transporter via Activation of Protein Kinase C
      Alicia E. Derbez, Rupal M. Mody and Linda L. Werling
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 306-314; DOI: https://doi.org/10.1124/jpet.301.1.306
  17. Molet, Sophie

    1. You have access
      The Selective Phosphodiesterase 4 Inhibitor RP 73-401 Reduced Matrix Metalloproteinase 9 Activity and Transforming Growth Factor-β Release During Acute Lung Injury in Mice: The Role of the Balance Between Tumor Necrosis Factor-α and Interleukin-10
      Marianne Corbel, Noëlla Germain, Jérôme Lanchou, Sophie Molet, Patricia M. R. e Silva, Marco A. Martins, Elisabeth Boichot and Vincent Lagente
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 258-265; DOI: https://doi.org/10.1124/jpet.301.1.258
  18. Montoliu, Carmina

    1. You have access
      Prevention of in Vivo Excitotoxicity by a Family of Trialkylglycines, a Novel Class of Neuroprotectants
      Carmina Montoliu, Marc Humet, Juan-José Canales, Jozef Burda, Rosa Planells-Cases, Francisco Sánchez-Baeza, Teresa Carbonell, Enrique Pérez-Payá, Angel Messeguer, Antonio Ferrer-Montiel and Vicente Felipo
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 29-36; DOI: https://doi.org/10.1124/jpet.301.1.29
  19. Mürdter, Thomas E.

    1. You have access
      Dose Optimization of a Doxorubicin Prodrug (HMR 1826) in Isolated Perfused Human Lungs: Low Tumor pH Promotes Prodrug Activation by β-Glucuronidase
      Thomas E. Mürdter, Godehard Friedel, Janne T. Backman, Monika McClellan, Monika Schick, Manfred Gerken, Klaus Bosslet, Peter Fritz, Heikki Toomes, Heyo K. Kroemer and Bernhard Sperker
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 223-228; DOI: https://doi.org/10.1124/jpet.301.1.223
  20. Myers, Michael J.

    1. You have access
      Influence of Porcine Actinobacillus pleuropneumoniae Infection and Dexamethasone on the Pharmacokinetic Parameters of Enrofloxacin
      Lynn O. Post, Carol V. Cope, Dorothy E. Farrell, John D. Baker and Michael J. Myers
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 217-222; DOI: https://doi.org/10.1124/jpet.301.1.217

N

  1. Nagao, Taku

    1. You have access
      β1-Selective Agonist (−)-1-(3,4-Dimethoxyphenetylamino)-3-(3,4-dihydroxy)-2-propanol [(−)-RO363] Differentially Interacts with Key Amino Acids Responsible for β1-Selective Binding in Resting and Active States
      Yoshiyuki Sugimoto, Reiko Fujisawa, Ryuji Tanimura, Anne Laure Lattion, Susanna Cotecchia, Gozoh Tsujimoto, Taku Nagao and Hitoshi Kurose
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 51-58; DOI: https://doi.org/10.1124/jpet.301.1.51
  2. Nakai, Masami

    1. You have access
      Attenuation of Scopolamine-Induced and Age-Associated Memory Impairments by the Sigma and 5-Hydroxytryptamine1A Receptor Agonist OPC-14523 (1-{3-[4-(3-chlorophenyl)-1-piperazinyl]propyl}-5-methoxy-3,4-dihydro-2[1H]-quinolinone monomethanesulfonate)
      Katsura Tottori, Masami Nakai, Yasufumi Uwahodo, Takashi Miwa, Sakiko Yamada, Yasuo Oshiro, Tetsuro Kikuchi and C. Anthony Altar
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 249-257; DOI: https://doi.org/10.1124/jpet.301.1.249
  3. Nakase, Hiroshi

    1. You have access
      New Cytokine Delivery System Using Gelatin Microspheres Containing Interleukin-10 for Experimental Inflammatory Bowel Disease
      Hiroshi Nakase, Kazuichi Okazaki, Yasuhiko Tabata, Makoto Ozeki, Norihiko Watanabe, Masaya Ohana, Suguru Uose, Kazushige Uchida, Toshiki Nishi, Minoru Mastuura, Hiroyuki Tamaki, Toshiyuki Itoh, Chiharu Kawanami and Tsutomu Chiba
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 59-65; DOI: https://doi.org/10.1124/jpet.301.1.59
  4. Nankervis, R.

    1. You have access
      Intranasal Delivery of Morphine
      L. Illum, P. Watts, A. N. Fisher, M. Hinchcliffe, H. Norbury, I. Jabbal-Gill, R. Nankervis and S. S. Davis
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 391-400; DOI: https://doi.org/10.1124/jpet.301.1.391
  5. Napier, T. Celeste

    1. You have access
      Alterations in Responses of Ventral Pallidal Neurons to Excitatory Amino Acids after Long-Term Dopamine Depletion
      Michael S. Turner, Laurence Mignon and T. Celeste Napier
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 371-381; DOI: https://doi.org/10.1124/jpet.301.1.371
  6. Narikawa, Shinichi

    1. You have access
      Human Organic Anion Transporters and Human Organic Cation Transporters Mediate Renal Transport of Prostaglandins
      Hiroaki Kimura, Michio Takeda, Shinichi Narikawa, Atsushi Enomoto, Kimiyoshi Ichida and Hitoshi Endou
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 293-298; DOI: https://doi.org/10.1124/jpet.301.1.293
  7. Nathanson, Neil M.

    1. You have access
      Altered Cardiovascular Responses in Mice Lacking the M1 Muscarinic Acetylcholine Receptor
      Sandrine N. Hardouin, Keith N. Richmond, Andrew Zimmerman, Susan E. Hamilton, Eric O. Feigl and Neil M. Nathanson
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 129-137; DOI: https://doi.org/10.1124/jpet.301.1.129
  8. Nelson, Allen H.

    1. You have access
      The Angiotensin Type 1 Receptor Antagonist, Eprosartan, Attenuates the Progression of Renal Disease in Spontaneously Hypertensive Stroke-Prone Rats with Accelerated Hypertension
      Christian T. Abrahamsen, Frank C. Barone, Wallace G. Campbell, Allen H. Nelson, Lisa C. Contino, Mark A. Pullen, Eugene T. Grygielko, Richard M. Edwards, Nicholas J. Laping and David P. Brooks
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 21-28; DOI: https://doi.org/10.1124/jpet.301.1.21
  9. Németh, Zoltán H.

    1. You have access
      Inhibitors of ATP-Binding Cassette Transporters Suppress Interleukin-12 p40 Production and Major Histocompatibility Complex II Up-Regulation in Macrophages
      György Haskó, Edwin A. Deitch, Zoltán H. Németh, David G. Kuhel and Csaba Szabó
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 103-110; DOI: https://doi.org/10.1124/jpet.301.1.103
  10. Nerurkar, Sandhya

    1. You have access
      Sustained Activation of p38 Mitogen-Activated Protein Kinase Contributes to the Vascular Response to Injury
      Haisong Ju, Sandhya Nerurkar, Charles F. Sauermelch, Alan R. Olzinski, Rosanna Mirabile, Dawn Zimmerman, John C. Lee, Jerry Adams, Joseph Sisko, Marinella Berova and Robert N. Willette
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 15-20; DOI: https://doi.org/10.1124/jpet.301.1.15
  11. Newman, Leslie C.

    1. You have access
      Characterization of μ, κ, and δ Opioid Binding in Amphibian Whole Brain Tissue Homogenates
      Leslie C. Newman, Steven S. Sands, David R. Wallace and Craig W. Stevens
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 364-370; DOI: https://doi.org/10.1124/jpet.301.1.364
  12. Nishi, Toshiki

    1. You have access
      New Cytokine Delivery System Using Gelatin Microspheres Containing Interleukin-10 for Experimental Inflammatory Bowel Disease
      Hiroshi Nakase, Kazuichi Okazaki, Yasuhiko Tabata, Makoto Ozeki, Norihiko Watanabe, Masaya Ohana, Suguru Uose, Kazushige Uchida, Toshiki Nishi, Minoru Mastuura, Hiroyuki Tamaki, Toshiyuki Itoh, Chiharu Kawanami and Tsutomu Chiba
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 59-65; DOI: https://doi.org/10.1124/jpet.301.1.59
  13. Norbury, H.

    1. You have access
      Intranasal Delivery of Morphine
      L. Illum, P. Watts, A. N. Fisher, M. Hinchcliffe, H. Norbury, I. Jabbal-Gill, R. Nankervis and S. S. Davis
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 391-400; DOI: https://doi.org/10.1124/jpet.301.1.391

O

  1. Oganesian, Aram

    1. You have access
      Identification of a Novel Route of Extraction of Sirolimus in Human Small Intestine: Roles of Metabolism and Secretion
      Mary F. Paine, Louis Y. Leung, H. K. Lim, Kecheng Liao, Aram Oganesian, Mei-Yi Zhang, Kenneth E. Thummel and Paul B. Watkins
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 174-186; DOI: https://doi.org/10.1124/jpet.301.1.174
  2. Ogden, Brian A.

    1. You have access
      Cardiovascular Responses Elicited by the “Binge” Administration of Methamphetamine
      Kurt J. Varner, Brian A. Ogden, Joseph Delcarpio and Suzanne Meleg-Smith
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 152-159; DOI: https://doi.org/10.1124/jpet.301.1.152
  3. Ohana, Masaya

    1. You have access
      New Cytokine Delivery System Using Gelatin Microspheres Containing Interleukin-10 for Experimental Inflammatory Bowel Disease
      Hiroshi Nakase, Kazuichi Okazaki, Yasuhiko Tabata, Makoto Ozeki, Norihiko Watanabe, Masaya Ohana, Suguru Uose, Kazushige Uchida, Toshiki Nishi, Minoru Mastuura, Hiroyuki Tamaki, Toshiyuki Itoh, Chiharu Kawanami and Tsutomu Chiba
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 59-65; DOI: https://doi.org/10.1124/jpet.301.1.59
  4. Oka, Masahiko

    1. You have access
      Inhibitors of Pentose Phosphate Pathway Cause Vasodilation: Involvement of Voltage-Gated Potassium Channels
      Sachin A. Gupte, Kai-Xun Li, Takao Okada, Koichi Sato and Masahiko Oka
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 299-305; DOI: https://doi.org/10.1124/jpet.301.1.299
  5. Okada, Takao

    1. You have access
      Inhibitors of Pentose Phosphate Pathway Cause Vasodilation: Involvement of Voltage-Gated Potassium Channels
      Sachin A. Gupte, Kai-Xun Li, Takao Okada, Koichi Sato and Masahiko Oka
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 299-305; DOI: https://doi.org/10.1124/jpet.301.1.299
  6. Okazaki, Kazuichi

    1. You have access
      New Cytokine Delivery System Using Gelatin Microspheres Containing Interleukin-10 for Experimental Inflammatory Bowel Disease
      Hiroshi Nakase, Kazuichi Okazaki, Yasuhiko Tabata, Makoto Ozeki, Norihiko Watanabe, Masaya Ohana, Suguru Uose, Kazushige Uchida, Toshiki Nishi, Minoru Mastuura, Hiroyuki Tamaki, Toshiyuki Itoh, Chiharu Kawanami and Tsutomu Chiba
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 59-65; DOI: https://doi.org/10.1124/jpet.301.1.59
  7. Olzinski, Alan R.

    1. You have access
      Sustained Activation of p38 Mitogen-Activated Protein Kinase Contributes to the Vascular Response to Injury
      Haisong Ju, Sandhya Nerurkar, Charles F. Sauermelch, Alan R. Olzinski, Rosanna Mirabile, Dawn Zimmerman, John C. Lee, Jerry Adams, Joseph Sisko, Marinella Berova and Robert N. Willette
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 15-20; DOI: https://doi.org/10.1124/jpet.301.1.15
  8. Omar, Amal G.

    1. You have access
      Cyclosporine Adversely Affects Baroreflexes via Inhibition of Testosterone Modulation of Cardiac Vagal Control
      Mahmoud M. El-Mas, Elham A. Afify, Amal G. Omar and Fouad M. Sharabi
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 346-354; DOI: https://doi.org/10.1124/jpet.301.1.346
  9. Oshiro, Yasuo

    1. You have access
      Attenuation of Scopolamine-Induced and Age-Associated Memory Impairments by the Sigma and 5-Hydroxytryptamine1A Receptor Agonist OPC-14523 (1-{3-[4-(3-chlorophenyl)-1-piperazinyl]propyl}-5-methoxy-3,4-dihydro-2[1H]-quinolinone monomethanesulfonate)
      Katsura Tottori, Masami Nakai, Yasufumi Uwahodo, Takashi Miwa, Sakiko Yamada, Yasuo Oshiro, Tetsuro Kikuchi and C. Anthony Altar
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 249-257; DOI: https://doi.org/10.1124/jpet.301.1.249
  10. Ozeki, Makoto

    1. You have access
      New Cytokine Delivery System Using Gelatin Microspheres Containing Interleukin-10 for Experimental Inflammatory Bowel Disease
      Hiroshi Nakase, Kazuichi Okazaki, Yasuhiko Tabata, Makoto Ozeki, Norihiko Watanabe, Masaya Ohana, Suguru Uose, Kazushige Uchida, Toshiki Nishi, Minoru Mastuura, Hiroyuki Tamaki, Toshiyuki Itoh, Chiharu Kawanami and Tsutomu Chiba
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 59-65; DOI: https://doi.org/10.1124/jpet.301.1.59

P

  1. Paine, Mary F.

    1. You have access
      Identification of a Novel Route of Extraction of Sirolimus in Human Small Intestine: Roles of Metabolism and Secretion
      Mary F. Paine, Louis Y. Leung, H. K. Lim, Kecheng Liao, Aram Oganesian, Mei-Yi Zhang, Kenneth E. Thummel and Paul B. Watkins
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 174-186; DOI: https://doi.org/10.1124/jpet.301.1.174
  2. Pandey, Ghanshyam N.

    1. You have access
      Differential Effects of Haloperidol and Clozapine on [3H]cAMP Binding, Protein Kinase A (PKA) Activity, and mRNA and Protein Expression of Selective Regulatory and Catalytic Subunit Isoforms of PKA in Rat Brain
      Yogesh Dwivedi, Hooriyah S. Rizavi and Ghanshyam N. Pandey
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 197-209; DOI: https://doi.org/10.1124/jpet.301.1.197
  3. Pascal, Marc

    1. You have access
      4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine Hydrochloride (SSR125543A): A Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. I. Biochemical and Pharmacological Characterization
      Danielle Gully, Michel Geslin, Laurence Serva, Evelyne Fontaine, Pierre Roger, Christine Lair, Valerie Darre, Claudine Marcy, Pierre-Eric Rouby, Jacques Simiand, Josette Guitard, Georgette Gout, Regis Steinberg, Daniel Rodier, Guy Griebel, Philippe Soubrie, Marc Pascal, Rebecca Pruss, Bernard Scatton, Jean-Pierre Maffrand and Gerard Le Fur
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 322-332; DOI: https://doi.org/10.1124/jpet.301.1.322
  4. Pérez-Payá, Enrique

    1. You have access
      Prevention of in Vivo Excitotoxicity by a Family of Trialkylglycines, a Novel Class of Neuroprotectants
      Carmina Montoliu, Marc Humet, Juan-José Canales, Jozef Burda, Rosa Planells-Cases, Francisco Sánchez-Baeza, Teresa Carbonell, Enrique Pérez-Payá, Angel Messeguer, Antonio Ferrer-Montiel and Vicente Felipo
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 29-36; DOI: https://doi.org/10.1124/jpet.301.1.29
  5. Planells-Cases, Rosa

    1. You have access
      Prevention of in Vivo Excitotoxicity by a Family of Trialkylglycines, a Novel Class of Neuroprotectants
      Carmina Montoliu, Marc Humet, Juan-José Canales, Jozef Burda, Rosa Planells-Cases, Francisco Sánchez-Baeza, Teresa Carbonell, Enrique Pérez-Payá, Angel Messeguer, Antonio Ferrer-Montiel and Vicente Felipo
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 29-36; DOI: https://doi.org/10.1124/jpet.301.1.29
  6. Pönicke, Klaus

    1. You have access
      Differential Effects of Bucindolol and Carvedilol on Noradenaline-Induced Hypertrophic Response in Ventricular Cardiomyocytes of Adult Rats
      Klaus Pönicke, Ingrid Heinroth-Hoffmann and Otto-Erich Brodde
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 71-76; DOI: https://doi.org/10.1124/jpet.301.1.71
  7. Post, Lynn O.

    1. You have access
      Influence of Porcine Actinobacillus pleuropneumoniae Infection and Dexamethasone on the Pharmacokinetic Parameters of Enrofloxacin
      Lynn O. Post, Carol V. Cope, Dorothy E. Farrell, John D. Baker and Michael J. Myers
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 217-222; DOI: https://doi.org/10.1124/jpet.301.1.217
  8. Potschka, Heidrun

    1. You have access
      Role of Multidrug Transporters in Pharmacoresistance to Antiepileptic Drugs
      Wolfgang Löscher and Heidrun Potschka
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 7-14; DOI: https://doi.org/10.1124/jpet.301.1.7
  9. Pradhan, Tapas K.

    1. You have access
      Elucidation of Vasoactive Intestinal Peptide Pharmacophore for VPAC1 Receptors in Human, Rat, and Guinea Pig
      Hisato Igarashi, Tetsuhide Ito, Wei Hou, Samuel A. Mantey, Tapas K. Pradhan, Charles D. Ulrich, Simon J. Hocart, David H. Coy and Robert T. Jensen
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 37-50; DOI: https://doi.org/10.1124/jpet.301.1.37
  10. Pruss, Rebecca

    1. You have access
      4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine Hydrochloride (SSR125543A): A Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. I. Biochemical and Pharmacological Characterization
      Danielle Gully, Michel Geslin, Laurence Serva, Evelyne Fontaine, Pierre Roger, Christine Lair, Valerie Darre, Claudine Marcy, Pierre-Eric Rouby, Jacques Simiand, Josette Guitard, Georgette Gout, Regis Steinberg, Daniel Rodier, Guy Griebel, Philippe Soubrie, Marc Pascal, Rebecca Pruss, Bernard Scatton, Jean-Pierre Maffrand and Gerard Le Fur
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 322-332; DOI: https://doi.org/10.1124/jpet.301.1.322
  11. Pullen, Mark A.

    1. You have access
      The Angiotensin Type 1 Receptor Antagonist, Eprosartan, Attenuates the Progression of Renal Disease in Spontaneously Hypertensive Stroke-Prone Rats with Accelerated Hypertension
      Christian T. Abrahamsen, Frank C. Barone, Wallace G. Campbell, Allen H. Nelson, Lisa C. Contino, Mark A. Pullen, Eugene T. Grygielko, Richard M. Edwards, Nicholas J. Laping and David P. Brooks
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 21-28; DOI: https://doi.org/10.1124/jpet.301.1.21

Q

  1. Qu, Hong

    1. You have access
      Pharmacology and Toxicology of Astrocyte-Neuron Glutamate Transport and Cycling
      Ursula Sonnewald, Hong Qu and Michael Aschner
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 1-6; DOI: https://doi.org/10.1124/jpet.301.1.1

R

  1. Redl, Heinz

    1. You have access
      Tranexamic Acid, a Widely Used Antifibrinolytic Agent, Causes Convulsions by a γ-Aminobutyric AcidA Receptor Antagonistic Effect
      Roman Furtmüller, Michael G. Schlag, Michael Berger, Rudolf Hopf, Sigismund Huck, Werner Sieghart and Heinz Redl
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 168-173; DOI: https://doi.org/10.1124/jpet.301.1.168
  2. Richmond, Keith N.

    1. You have access
      Altered Cardiovascular Responses in Mice Lacking the M1 Muscarinic Acetylcholine Receptor
      Sandrine N. Hardouin, Keith N. Richmond, Andrew Zimmerman, Susan E. Hamilton, Eric O. Feigl and Neil M. Nathanson
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 129-137; DOI: https://doi.org/10.1124/jpet.301.1.129
  3. Riley, R. J.

    1. You have access
      In Vitro Analysis of Human Drug Glucuronidation and Prediction of in Vivo Metabolic Clearance
      M. G. Soars, B. Burchell and R. J. Riley
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 382-390; DOI: https://doi.org/10.1124/jpet.301.1.382
  4. Risbrough, V. B.

    1. You have access
      Effects of (±)-4-{[2-(1-Methyl-2-pyrrolidinyl)ethyl]thio}phenol Hydrochloride (SIB-1553A), a Selective Ligand for Nicotinic Acetylcholine Receptors, in Tests of Visual Attention and Distractibility in Rats and Monkeys
      A. V. Terry, V. B. Risbrough, J. J. Buccafusco and F. Menzaghi
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 284-292; DOI: https://doi.org/10.1124/jpet.301.1.284
  5. Rivier, Jean E.

    1. You have access
      Pharmacological Profile of a New, Potent, and Long-Acting Gonadotropin-Releasing Hormone Antagonist: Degarelix
      Pierre Broqua, Pierre J.-M. Riviere, P. Michael Conn, Jean E. Rivier, Michel L. Aubert and Jean-Louis Junien
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 95-102; DOI: https://doi.org/10.1124/jpet.301.1.95
  6. Riviere, Pierre J.-M.

    1. You have access
      Pharmacological Profile of a New, Potent, and Long-Acting Gonadotropin-Releasing Hormone Antagonist: Degarelix
      Pierre Broqua, Pierre J.-M. Riviere, P. Michael Conn, Jean E. Rivier, Michel L. Aubert and Jean-Louis Junien
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 95-102; DOI: https://doi.org/10.1124/jpet.301.1.95
  7. Rizavi, Hooriyah S.

    1. You have access
      Differential Effects of Haloperidol and Clozapine on [3H]cAMP Binding, Protein Kinase A (PKA) Activity, and mRNA and Protein Expression of Selective Regulatory and Catalytic Subunit Isoforms of PKA in Rat Brain
      Yogesh Dwivedi, Hooriyah S. Rizavi and Ghanshyam N. Pandey
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 197-209; DOI: https://doi.org/10.1124/jpet.301.1.197
  8. Rodier, Daniel

    1. You have access
      4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine Hydrochloride (SSR125543A): A Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. I. Biochemical and Pharmacological Characterization
      Danielle Gully, Michel Geslin, Laurence Serva, Evelyne Fontaine, Pierre Roger, Christine Lair, Valerie Darre, Claudine Marcy, Pierre-Eric Rouby, Jacques Simiand, Josette Guitard, Georgette Gout, Regis Steinberg, Daniel Rodier, Guy Griebel, Philippe Soubrie, Marc Pascal, Rebecca Pruss, Bernard Scatton, Jean-Pierre Maffrand and Gerard Le Fur
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 322-332; DOI: https://doi.org/10.1124/jpet.301.1.322
  9. Roger, Pierre

    1. You have access
      4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine Hydrochloride (SSR125543A): A Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. I. Biochemical and Pharmacological Characterization
      Danielle Gully, Michel Geslin, Laurence Serva, Evelyne Fontaine, Pierre Roger, Christine Lair, Valerie Darre, Claudine Marcy, Pierre-Eric Rouby, Jacques Simiand, Josette Guitard, Georgette Gout, Regis Steinberg, Daniel Rodier, Guy Griebel, Philippe Soubrie, Marc Pascal, Rebecca Pruss, Bernard Scatton, Jean-Pierre Maffrand and Gerard Le Fur
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 322-332; DOI: https://doi.org/10.1124/jpet.301.1.322
    2. You have access
      4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine Hydrochloride (SSR125543A), a Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. II. Characterization in Rodent Models of Stress-Related Disorders
      Guy Griebel, Jacques Simiand, Régis Steinberg, Mireille Jung, Danielle Gully, Pierre Roger, Michel Geslin, Bernard Scatton, Jean-Pierre Maffrand and Philippe Soubrié
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 333-345; DOI: https://doi.org/10.1124/jpet.301.1.333
  10. Rouby, Pierre-Eric

    1. You have access
      4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine Hydrochloride (SSR125543A): A Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. I. Biochemical and Pharmacological Characterization
      Danielle Gully, Michel Geslin, Laurence Serva, Evelyne Fontaine, Pierre Roger, Christine Lair, Valerie Darre, Claudine Marcy, Pierre-Eric Rouby, Jacques Simiand, Josette Guitard, Georgette Gout, Regis Steinberg, Daniel Rodier, Guy Griebel, Philippe Soubrie, Marc Pascal, Rebecca Pruss, Bernard Scatton, Jean-Pierre Maffrand and Gerard Le Fur
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 322-332; DOI: https://doi.org/10.1124/jpet.301.1.322
  11. Rucki, Marian

    1. You have access
      Novel Glutathione-Dependent Thiopurine Prodrugs: Evidence for Enhanced Cytotoxicity in Tumor Cells and for Decreased Bone Marrow Toxicity in Mice
      Sjofn Gunnarsdottir, Marian Rucki and Adnan A. Elfarra
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 77-86; DOI: https://doi.org/10.1124/jpet.301.1.77

S

  1. Sánchez-Baeza, Francisco

    1. You have access
      Prevention of in Vivo Excitotoxicity by a Family of Trialkylglycines, a Novel Class of Neuroprotectants
      Carmina Montoliu, Marc Humet, Juan-José Canales, Jozef Burda, Rosa Planells-Cases, Francisco Sánchez-Baeza, Teresa Carbonell, Enrique Pérez-Payá, Angel Messeguer, Antonio Ferrer-Montiel and Vicente Felipo
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 29-36; DOI: https://doi.org/10.1124/jpet.301.1.29
  2. Sands, Steven S.

    1. You have access
      Characterization of μ, κ, and δ Opioid Binding in Amphibian Whole Brain Tissue Homogenates
      Leslie C. Newman, Steven S. Sands, David R. Wallace and Craig W. Stevens
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 364-370; DOI: https://doi.org/10.1124/jpet.301.1.364
  3. Sarkar, Dipak K.

    1. You have access
      Role of Protein Kinase C in Control of Ethanol-Modulated β-Endorphin Release from Hypothalamic Neurons in Primary Cultures
      Alok De, Nadka Boyadjieva and Dipak K. Sarkar
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 119-128; DOI: https://doi.org/10.1124/jpet.301.1.119
  4. Sato, Koichi

    1. You have access
      Inhibitors of Pentose Phosphate Pathway Cause Vasodilation: Involvement of Voltage-Gated Potassium Channels
      Sachin A. Gupte, Kai-Xun Li, Takao Okada, Koichi Sato and Masahiko Oka
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 299-305; DOI: https://doi.org/10.1124/jpet.301.1.299
  5. Sauermelch, Charles F.

    1. You have access
      Sustained Activation of p38 Mitogen-Activated Protein Kinase Contributes to the Vascular Response to Injury
      Haisong Ju, Sandhya Nerurkar, Charles F. Sauermelch, Alan R. Olzinski, Rosanna Mirabile, Dawn Zimmerman, John C. Lee, Jerry Adams, Joseph Sisko, Marinella Berova and Robert N. Willette
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 15-20; DOI: https://doi.org/10.1124/jpet.301.1.15
  6. Scatton, Bernard

    1. You have access
      4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine Hydrochloride (SSR125543A): A Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. I. Biochemical and Pharmacological Characterization
      Danielle Gully, Michel Geslin, Laurence Serva, Evelyne Fontaine, Pierre Roger, Christine Lair, Valerie Darre, Claudine Marcy, Pierre-Eric Rouby, Jacques Simiand, Josette Guitard, Georgette Gout, Regis Steinberg, Daniel Rodier, Guy Griebel, Philippe Soubrie, Marc Pascal, Rebecca Pruss, Bernard Scatton, Jean-Pierre Maffrand and Gerard Le Fur
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 322-332; DOI: https://doi.org/10.1124/jpet.301.1.322
    2. You have access
      4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine Hydrochloride (SSR125543A), a Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. II. Characterization in Rodent Models of Stress-Related Disorders
      Guy Griebel, Jacques Simiand, Régis Steinberg, Mireille Jung, Danielle Gully, Pierre Roger, Michel Geslin, Bernard Scatton, Jean-Pierre Maffrand and Philippe Soubrié
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 333-345; DOI: https://doi.org/10.1124/jpet.301.1.333
  7. Schick, Monika

    1. You have access
      Dose Optimization of a Doxorubicin Prodrug (HMR 1826) in Isolated Perfused Human Lungs: Low Tumor pH Promotes Prodrug Activation by β-Glucuronidase
      Thomas E. Mürdter, Godehard Friedel, Janne T. Backman, Monika McClellan, Monika Schick, Manfred Gerken, Klaus Bosslet, Peter Fritz, Heikki Toomes, Heyo K. Kroemer and Bernhard Sperker
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 223-228; DOI: https://doi.org/10.1124/jpet.301.1.223
  8. Schlag, Michael G.

    1. You have access
      Tranexamic Acid, a Widely Used Antifibrinolytic Agent, Causes Convulsions by a γ-Aminobutyric AcidA Receptor Antagonistic Effect
      Roman Furtmüller, Michael G. Schlag, Michael Berger, Rudolf Hopf, Sigismund Huck, Werner Sieghart and Heinz Redl
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 168-173; DOI: https://doi.org/10.1124/jpet.301.1.168
  9. Serva, Laurence

    1. You have access
      4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine Hydrochloride (SSR125543A): A Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. I. Biochemical and Pharmacological Characterization
      Danielle Gully, Michel Geslin, Laurence Serva, Evelyne Fontaine, Pierre Roger, Christine Lair, Valerie Darre, Claudine Marcy, Pierre-Eric Rouby, Jacques Simiand, Josette Guitard, Georgette Gout, Regis Steinberg, Daniel Rodier, Guy Griebel, Philippe Soubrie, Marc Pascal, Rebecca Pruss, Bernard Scatton, Jean-Pierre Maffrand and Gerard Le Fur
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 322-332; DOI: https://doi.org/10.1124/jpet.301.1.322
  10. Shankaran, Mahalakshmi

    1. You have access
      3,4-Methylenedioxymethamphetamine Produces Glycogenolysis and Increases the Extracellular Concentration of Glucose in the Rat Brain
      Altaf S. Darvesh, Mahalakshmi Shankaran and Gary A. Gudelsky
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 138-144; DOI: https://doi.org/10.1124/jpet.301.1.138
  11. Sharabi, Fouad M.

    1. You have access
      Cyclosporine Adversely Affects Baroreflexes via Inhibition of Testosterone Modulation of Cardiac Vagal Control
      Mahmoud M. El-Mas, Elham A. Afify, Amal G. Omar and Fouad M. Sharabi
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 346-354; DOI: https://doi.org/10.1124/jpet.301.1.346
  12. Shin, Hwa Kyoung

    1. You have access
      Neuroprotective Effect of (2S,3S,4R)-N"-cyano-N-(6-amino-3, 4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2H-benzopyran-4-yl)-N′-benzylguanidine (KR-31378), a Benzopyran Analog, against Focal Ischemic Brain Damage in Rats
      Ki Whan Hong, Ki Young Kim, Jeong Hyun Lee, Hwa Kyoung Shin, Yong Geun Kwak, Sun-Ok Kim, Hong Lim and Sung-Eun Yoo
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 210-216; DOI: https://doi.org/10.1124/jpet.301.1.210
  13. Sieghart, Werner

    1. You have access
      Tranexamic Acid, a Widely Used Antifibrinolytic Agent, Causes Convulsions by a γ-Aminobutyric AcidA Receptor Antagonistic Effect
      Roman Furtmüller, Michael G. Schlag, Michael Berger, Rudolf Hopf, Sigismund Huck, Werner Sieghart and Heinz Redl
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 168-173; DOI: https://doi.org/10.1124/jpet.301.1.168
  14. Simiand, Jacques

    1. You have access
      4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine Hydrochloride (SSR125543A): A Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. I. Biochemical and Pharmacological Characterization
      Danielle Gully, Michel Geslin, Laurence Serva, Evelyne Fontaine, Pierre Roger, Christine Lair, Valerie Darre, Claudine Marcy, Pierre-Eric Rouby, Jacques Simiand, Josette Guitard, Georgette Gout, Regis Steinberg, Daniel Rodier, Guy Griebel, Philippe Soubrie, Marc Pascal, Rebecca Pruss, Bernard Scatton, Jean-Pierre Maffrand and Gerard Le Fur
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 322-332; DOI: https://doi.org/10.1124/jpet.301.1.322
    2. You have access
      4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine Hydrochloride (SSR125543A), a Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. II. Characterization in Rodent Models of Stress-Related Disorders
      Guy Griebel, Jacques Simiand, Régis Steinberg, Mireille Jung, Danielle Gully, Pierre Roger, Michel Geslin, Bernard Scatton, Jean-Pierre Maffrand and Philippe Soubrié
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 333-345; DOI: https://doi.org/10.1124/jpet.301.1.333
  15. Sisko, Joseph

    1. You have access
      Sustained Activation of p38 Mitogen-Activated Protein Kinase Contributes to the Vascular Response to Injury
      Haisong Ju, Sandhya Nerurkar, Charles F. Sauermelch, Alan R. Olzinski, Rosanna Mirabile, Dawn Zimmerman, John C. Lee, Jerry Adams, Joseph Sisko, Marinella Berova and Robert N. Willette
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 15-20; DOI: https://doi.org/10.1124/jpet.301.1.15
  16. Skowronski, Mariusz T.

    1. You have access
      Activation of Endogenous Nitric Oxide Synthase Coupled with Methacholine-Induced Exocytosis in Rat Parotid Acinar Cells
      Yasuko Ishikawa, Hirokazu Iida, Mariusz T. Skowronski and Hajime Ishida
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 355-363; DOI: https://doi.org/10.1124/jpet.301.1.355
  17. Soars, M. G.

    1. You have access
      In Vitro Analysis of Human Drug Glucuronidation and Prediction of in Vivo Metabolic Clearance
      M. G. Soars, B. Burchell and R. J. Riley
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 382-390; DOI: https://doi.org/10.1124/jpet.301.1.382
  18. Sonnewald, Ursula

    1. You have access
      Pharmacology and Toxicology of Astrocyte-Neuron Glutamate Transport and Cycling
      Ursula Sonnewald, Hong Qu and Michael Aschner
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 1-6; DOI: https://doi.org/10.1124/jpet.301.1.1
  19. Soubrie, Philippe

    1. You have access
      4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine Hydrochloride (SSR125543A): A Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. I. Biochemical and Pharmacological Characterization
      Danielle Gully, Michel Geslin, Laurence Serva, Evelyne Fontaine, Pierre Roger, Christine Lair, Valerie Darre, Claudine Marcy, Pierre-Eric Rouby, Jacques Simiand, Josette Guitard, Georgette Gout, Regis Steinberg, Daniel Rodier, Guy Griebel, Philippe Soubrie, Marc Pascal, Rebecca Pruss, Bernard Scatton, Jean-Pierre Maffrand and Gerard Le Fur
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 322-332; DOI: https://doi.org/10.1124/jpet.301.1.322
  20. Soubrié, Philippe

    1. You have access
      4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine Hydrochloride (SSR125543A), a Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. II. Characterization in Rodent Models of Stress-Related Disorders
      Guy Griebel, Jacques Simiand, Régis Steinberg, Mireille Jung, Danielle Gully, Pierre Roger, Michel Geslin, Bernard Scatton, Jean-Pierre Maffrand and Philippe Soubrié
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 333-345; DOI: https://doi.org/10.1124/jpet.301.1.333
  21. Sperker, Bernhard

    1. You have access
      Dose Optimization of a Doxorubicin Prodrug (HMR 1826) in Isolated Perfused Human Lungs: Low Tumor pH Promotes Prodrug Activation by β-Glucuronidase
      Thomas E. Mürdter, Godehard Friedel, Janne T. Backman, Monika McClellan, Monika Schick, Manfred Gerken, Klaus Bosslet, Peter Fritz, Heikki Toomes, Heyo K. Kroemer and Bernhard Sperker
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 223-228; DOI: https://doi.org/10.1124/jpet.301.1.223
  22. Srivatsa, Kousthub

    1. You have access
      Priming of Alveolar Macrophage Respiratory Burst by H2O2 Is Prevented by Phosphatidylcholine-Specific Phospholipase C Inhibitor Tricyclodecan-9-yl-xanthate (D609)
      Julio Girón-Calle, Kousthub Srivatsa and Henry Jay Forman
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 87-94; DOI: https://doi.org/10.1124/jpet.301.1.87
  23. Steinberg, Regis

    1. You have access
      4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine Hydrochloride (SSR125543A): A Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. I. Biochemical and Pharmacological Characterization
      Danielle Gully, Michel Geslin, Laurence Serva, Evelyne Fontaine, Pierre Roger, Christine Lair, Valerie Darre, Claudine Marcy, Pierre-Eric Rouby, Jacques Simiand, Josette Guitard, Georgette Gout, Regis Steinberg, Daniel Rodier, Guy Griebel, Philippe Soubrie, Marc Pascal, Rebecca Pruss, Bernard Scatton, Jean-Pierre Maffrand and Gerard Le Fur
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 322-332; DOI: https://doi.org/10.1124/jpet.301.1.322
  24. Steinberg, Régis

    1. You have access
      4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine Hydrochloride (SSR125543A), a Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. II. Characterization in Rodent Models of Stress-Related Disorders
      Guy Griebel, Jacques Simiand, Régis Steinberg, Mireille Jung, Danielle Gully, Pierre Roger, Michel Geslin, Bernard Scatton, Jean-Pierre Maffrand and Philippe Soubrié
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 333-345; DOI: https://doi.org/10.1124/jpet.301.1.333
  25. Stevens, Craig W.

    1. You have access
      Characterization of μ, κ, and δ Opioid Binding in Amphibian Whole Brain Tissue Homogenates
      Leslie C. Newman, Steven S. Sands, David R. Wallace and Craig W. Stevens
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 364-370; DOI: https://doi.org/10.1124/jpet.301.1.364
  26. Su, Sheng-Fang

    1. You have access
      Differential Effects of Sarcolemmal and Mitochondrial KATP Channels Activated by 17β-Estradiol on Reperfusion Arrhythmias and Infarct Sizes in Canine Hearts
      Chang-Her Tsai, Sheng-Fang Su, Tsai-Fwu Chou and Tsung-Ming Lee
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 234-240; DOI: https://doi.org/10.1124/jpet.301.1.234
  27. Sugimoto, Yoshiyuki

    1. You have access
      β1-Selective Agonist (−)-1-(3,4-Dimethoxyphenetylamino)-3-(3,4-dihydroxy)-2-propanol [(−)-RO363] Differentially Interacts with Key Amino Acids Responsible for β1-Selective Binding in Resting and Active States
      Yoshiyuki Sugimoto, Reiko Fujisawa, Ryuji Tanimura, Anne Laure Lattion, Susanna Cotecchia, Gozoh Tsujimoto, Taku Nagao and Hitoshi Kurose
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 51-58; DOI: https://doi.org/10.1124/jpet.301.1.51
  28. Szabó, Csaba

    1. You have access
      Inhibitors of ATP-Binding Cassette Transporters Suppress Interleukin-12 p40 Production and Major Histocompatibility Complex II Up-Regulation in Macrophages
      György Haskó, Edwin A. Deitch, Zoltán H. Németh, David G. Kuhel and Csaba Szabó
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 103-110; DOI: https://doi.org/10.1124/jpet.301.1.103

T

  1. Tabata, Yasuhiko

    1. You have access
      New Cytokine Delivery System Using Gelatin Microspheres Containing Interleukin-10 for Experimental Inflammatory Bowel Disease
      Hiroshi Nakase, Kazuichi Okazaki, Yasuhiko Tabata, Makoto Ozeki, Norihiko Watanabe, Masaya Ohana, Suguru Uose, Kazushige Uchida, Toshiki Nishi, Minoru Mastuura, Hiroyuki Tamaki, Toshiyuki Itoh, Chiharu Kawanami and Tsutomu Chiba
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 59-65; DOI: https://doi.org/10.1124/jpet.301.1.59
  2. Takeda, Michio

    1. You have access
      Human Organic Anion Transporters and Human Organic Cation Transporters Mediate Renal Transport of Prostaglandins
      Hiroaki Kimura, Michio Takeda, Shinichi Narikawa, Atsushi Enomoto, Kimiyoshi Ichida and Hitoshi Endou
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 293-298; DOI: https://doi.org/10.1124/jpet.301.1.293
  3. Tamaki, Hiroyuki

    1. You have access
      New Cytokine Delivery System Using Gelatin Microspheres Containing Interleukin-10 for Experimental Inflammatory Bowel Disease
      Hiroshi Nakase, Kazuichi Okazaki, Yasuhiko Tabata, Makoto Ozeki, Norihiko Watanabe, Masaya Ohana, Suguru Uose, Kazushige Uchida, Toshiki Nishi, Minoru Mastuura, Hiroyuki Tamaki, Toshiyuki Itoh, Chiharu Kawanami and Tsutomu Chiba
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 59-65; DOI: https://doi.org/10.1124/jpet.301.1.59
  4. Tanimura, Ryuji

    1. You have access
      β1-Selective Agonist (−)-1-(3,4-Dimethoxyphenetylamino)-3-(3,4-dihydroxy)-2-propanol [(−)-RO363] Differentially Interacts with Key Amino Acids Responsible for β1-Selective Binding in Resting and Active States
      Yoshiyuki Sugimoto, Reiko Fujisawa, Ryuji Tanimura, Anne Laure Lattion, Susanna Cotecchia, Gozoh Tsujimoto, Taku Nagao and Hitoshi Kurose
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 51-58; DOI: https://doi.org/10.1124/jpet.301.1.51
  5. Terry, A. V.

    1. You have access
      Effects of (±)-4-{[2-(1-Methyl-2-pyrrolidinyl)ethyl]thio}phenol Hydrochloride (SIB-1553A), a Selective Ligand for Nicotinic Acetylcholine Receptors, in Tests of Visual Attention and Distractibility in Rats and Monkeys
      A. V. Terry, V. B. Risbrough, J. J. Buccafusco and F. Menzaghi
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 284-292; DOI: https://doi.org/10.1124/jpet.301.1.284
  6. Thummel, Kenneth E.

    1. You have access
      Identification of a Novel Route of Extraction of Sirolimus in Human Small Intestine: Roles of Metabolism and Secretion
      Mary F. Paine, Louis Y. Leung, H. K. Lim, Kecheng Liao, Aram Oganesian, Mei-Yi Zhang, Kenneth E. Thummel and Paul B. Watkins
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 174-186; DOI: https://doi.org/10.1124/jpet.301.1.174
  7. Toomes, Heikki

    1. You have access
      Dose Optimization of a Doxorubicin Prodrug (HMR 1826) in Isolated Perfused Human Lungs: Low Tumor pH Promotes Prodrug Activation by β-Glucuronidase
      Thomas E. Mürdter, Godehard Friedel, Janne T. Backman, Monika McClellan, Monika Schick, Manfred Gerken, Klaus Bosslet, Peter Fritz, Heikki Toomes, Heyo K. Kroemer and Bernhard Sperker
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 223-228; DOI: https://doi.org/10.1124/jpet.301.1.223
  8. Tottori, Katsura

    1. You have access
      Attenuation of Scopolamine-Induced and Age-Associated Memory Impairments by the Sigma and 5-Hydroxytryptamine1A Receptor Agonist OPC-14523 (1-{3-[4-(3-chlorophenyl)-1-piperazinyl]propyl}-5-methoxy-3,4-dihydro-2[1H]-quinolinone monomethanesulfonate)
      Katsura Tottori, Masami Nakai, Yasufumi Uwahodo, Takashi Miwa, Sakiko Yamada, Yasuo Oshiro, Tetsuro Kikuchi and C. Anthony Altar
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 249-257; DOI: https://doi.org/10.1124/jpet.301.1.249
  9. Trifilieff, Alexandre

    1. You have access
      Pharmacological Profile of a Novel Phosphodiesterase 4 Inhibitor, 4-(8-Benzo[1,2,5]oxadiazol-5-yl-[1,7]naphthyridin-6-yl)-benzoic Acid (NVP-ABE171), a 1,7-Naphthyridine Derivative, with Anti-Inflammatory Activities
      Alexandre Trifilieff, Daniel Wyss, Christoph Walker, Lazzaro Mazzoni and Rene Hersperger
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 241-248; DOI: https://doi.org/10.1124/jpet.301.1.241
  10. Tsai, Chang-Her

    1. You have access
      Differential Effects of Sarcolemmal and Mitochondrial KATP Channels Activated by 17β-Estradiol on Reperfusion Arrhythmias and Infarct Sizes in Canine Hearts
      Chang-Her Tsai, Sheng-Fang Su, Tsai-Fwu Chou and Tsung-Ming Lee
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 234-240; DOI: https://doi.org/10.1124/jpet.301.1.234
  11. Tsujimoto, Gozoh

    1. You have access
      β1-Selective Agonist (−)-1-(3,4-Dimethoxyphenetylamino)-3-(3,4-dihydroxy)-2-propanol [(−)-RO363] Differentially Interacts with Key Amino Acids Responsible for β1-Selective Binding in Resting and Active States
      Yoshiyuki Sugimoto, Reiko Fujisawa, Ryuji Tanimura, Anne Laure Lattion, Susanna Cotecchia, Gozoh Tsujimoto, Taku Nagao and Hitoshi Kurose
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 51-58; DOI: https://doi.org/10.1124/jpet.301.1.51
  12. Turner, Michael S.

    1. You have access
      Alterations in Responses of Ventral Pallidal Neurons to Excitatory Amino Acids after Long-Term Dopamine Depletion
      Michael S. Turner, Laurence Mignon and T. Celeste Napier
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 371-381; DOI: https://doi.org/10.1124/jpet.301.1.371

U

  1. Uchida, Kazushige

    1. You have access
      New Cytokine Delivery System Using Gelatin Microspheres Containing Interleukin-10 for Experimental Inflammatory Bowel Disease
      Hiroshi Nakase, Kazuichi Okazaki, Yasuhiko Tabata, Makoto Ozeki, Norihiko Watanabe, Masaya Ohana, Suguru Uose, Kazushige Uchida, Toshiki Nishi, Minoru Mastuura, Hiroyuki Tamaki, Toshiyuki Itoh, Chiharu Kawanami and Tsutomu Chiba
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 59-65; DOI: https://doi.org/10.1124/jpet.301.1.59
  2. Ulrich, Charles D.

    1. You have access
      Elucidation of Vasoactive Intestinal Peptide Pharmacophore for VPAC1 Receptors in Human, Rat, and Guinea Pig
      Hisato Igarashi, Tetsuhide Ito, Wei Hou, Samuel A. Mantey, Tapas K. Pradhan, Charles D. Ulrich, Simon J. Hocart, David H. Coy and Robert T. Jensen
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 37-50; DOI: https://doi.org/10.1124/jpet.301.1.37
  3. Uose, Suguru

    1. You have access
      New Cytokine Delivery System Using Gelatin Microspheres Containing Interleukin-10 for Experimental Inflammatory Bowel Disease
      Hiroshi Nakase, Kazuichi Okazaki, Yasuhiko Tabata, Makoto Ozeki, Norihiko Watanabe, Masaya Ohana, Suguru Uose, Kazushige Uchida, Toshiki Nishi, Minoru Mastuura, Hiroyuki Tamaki, Toshiyuki Itoh, Chiharu Kawanami and Tsutomu Chiba
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 59-65; DOI: https://doi.org/10.1124/jpet.301.1.59
  4. Uwahodo, Yasufumi

    1. You have access
      Attenuation of Scopolamine-Induced and Age-Associated Memory Impairments by the Sigma and 5-Hydroxytryptamine1A Receptor Agonist OPC-14523 (1-{3-[4-(3-chlorophenyl)-1-piperazinyl]propyl}-5-methoxy-3,4-dihydro-2[1H]-quinolinone monomethanesulfonate)
      Katsura Tottori, Masami Nakai, Yasufumi Uwahodo, Takashi Miwa, Sakiko Yamada, Yasuo Oshiro, Tetsuro Kikuchi and C. Anthony Altar
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 249-257; DOI: https://doi.org/10.1124/jpet.301.1.249

V

  1. Varner, Kurt J.

    1. You have access
      Cardiovascular Responses Elicited by the “Binge” Administration of Methamphetamine
      Kurt J. Varner, Brian A. Ogden, Joseph Delcarpio and Suzanne Meleg-Smith
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 152-159; DOI: https://doi.org/10.1124/jpet.301.1.152

W

  1. Walker, Christoph

    1. You have access
      Pharmacological Profile of a Novel Phosphodiesterase 4 Inhibitor, 4-(8-Benzo[1,2,5]oxadiazol-5-yl-[1,7]naphthyridin-6-yl)-benzoic Acid (NVP-ABE171), a 1,7-Naphthyridine Derivative, with Anti-Inflammatory Activities
      Alexandre Trifilieff, Daniel Wyss, Christoph Walker, Lazzaro Mazzoni and Rene Hersperger
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 241-248; DOI: https://doi.org/10.1124/jpet.301.1.241
  2. Wallace, David R.

    1. You have access
      Characterization of μ, κ, and δ Opioid Binding in Amphibian Whole Brain Tissue Homogenates
      Leslie C. Newman, Steven S. Sands, David R. Wallace and Craig W. Stevens
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 364-370; DOI: https://doi.org/10.1124/jpet.301.1.364
  3. Watanabe, Norihiko

    1. You have access
      New Cytokine Delivery System Using Gelatin Microspheres Containing Interleukin-10 for Experimental Inflammatory Bowel Disease
      Hiroshi Nakase, Kazuichi Okazaki, Yasuhiko Tabata, Makoto Ozeki, Norihiko Watanabe, Masaya Ohana, Suguru Uose, Kazushige Uchida, Toshiki Nishi, Minoru Mastuura, Hiroyuki Tamaki, Toshiyuki Itoh, Chiharu Kawanami and Tsutomu Chiba
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 59-65; DOI: https://doi.org/10.1124/jpet.301.1.59
  4. Watkins, Paul B.

    1. You have access
      Identification of a Novel Route of Extraction of Sirolimus in Human Small Intestine: Roles of Metabolism and Secretion
      Mary F. Paine, Louis Y. Leung, H. K. Lim, Kecheng Liao, Aram Oganesian, Mei-Yi Zhang, Kenneth E. Thummel and Paul B. Watkins
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 174-186; DOI: https://doi.org/10.1124/jpet.301.1.174
  5. Watts, P.

    1. You have access
      Intranasal Delivery of Morphine
      L. Illum, P. Watts, A. N. Fisher, M. Hinchcliffe, H. Norbury, I. Jabbal-Gill, R. Nankervis and S. S. Davis
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 391-400; DOI: https://doi.org/10.1124/jpet.301.1.391
  6. Webster, Leslie T.

    1. You have access
      Kinetic Interactions of Dopamine and Dobutamine with Human Catechol-O-methyltransferase and Monoamine Oxidase in Vitro
      Maohe Yan, Leslie T. Webster and Jeffrey L. Blumer
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 315-321; DOI: https://doi.org/10.1124/jpet.301.1.315
  7. Werling, Linda L.

    1. You have access
      ς2-Receptor Regulation of Dopamine Transporter via Activation of Protein Kinase C
      Alicia E. Derbez, Rupal M. Mody and Linda L. Werling
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 306-314; DOI: https://doi.org/10.1124/jpet.301.1.306
  8. Willette, Robert N.

    1. You have access
      Sustained Activation of p38 Mitogen-Activated Protein Kinase Contributes to the Vascular Response to Injury
      Haisong Ju, Sandhya Nerurkar, Charles F. Sauermelch, Alan R. Olzinski, Rosanna Mirabile, Dawn Zimmerman, John C. Lee, Jerry Adams, Joseph Sisko, Marinella Berova and Robert N. Willette
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 15-20; DOI: https://doi.org/10.1124/jpet.301.1.15
  9. Wyss, Daniel

    1. You have access
      Pharmacological Profile of a Novel Phosphodiesterase 4 Inhibitor, 4-(8-Benzo[1,2,5]oxadiazol-5-yl-[1,7]naphthyridin-6-yl)-benzoic Acid (NVP-ABE171), a 1,7-Naphthyridine Derivative, with Anti-Inflammatory Activities
      Alexandre Trifilieff, Daniel Wyss, Christoph Walker, Lazzaro Mazzoni and Rene Hersperger
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 241-248; DOI: https://doi.org/10.1124/jpet.301.1.241

Y

  1. Yamada, Sakiko

    1. You have access
      Attenuation of Scopolamine-Induced and Age-Associated Memory Impairments by the Sigma and 5-Hydroxytryptamine1A Receptor Agonist OPC-14523 (1-{3-[4-(3-chlorophenyl)-1-piperazinyl]propyl}-5-methoxy-3,4-dihydro-2[1H]-quinolinone monomethanesulfonate)
      Katsura Tottori, Masami Nakai, Yasufumi Uwahodo, Takashi Miwa, Sakiko Yamada, Yasuo Oshiro, Tetsuro Kikuchi and C. Anthony Altar
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 249-257; DOI: https://doi.org/10.1124/jpet.301.1.249
  2. Yan, Maohe

    1. You have access
      Kinetic Interactions of Dopamine and Dobutamine with Human Catechol-O-methyltransferase and Monoamine Oxidase in Vitro
      Maohe Yan, Leslie T. Webster and Jeffrey L. Blumer
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 315-321; DOI: https://doi.org/10.1124/jpet.301.1.315
  3. Yao, Lina

    1. You have access
      Ethanol Stimulates cAMP-Responsive Element (CRE)-Mediated Transcription via CRE-Binding Protein and cAMP-Dependent Protein Kinase
      Orna Asher, Thomas D. Cunningham, Lina Yao, Adrienne S. Gordon and Ivan Diamond
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 66-70; DOI: https://doi.org/10.1124/jpet.301.1.66
  4. Yoo, Sung-Eun

    1. You have access
      Neuroprotective Effect of (2S,3S,4R)-N"-cyano-N-(6-amino-3, 4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2H-benzopyran-4-yl)-N′-benzylguanidine (KR-31378), a Benzopyran Analog, against Focal Ischemic Brain Damage in Rats
      Ki Whan Hong, Ki Young Kim, Jeong Hyun Lee, Hwa Kyoung Shin, Yong Geun Kwak, Sun-Ok Kim, Hong Lim and Sung-Eun Yoo
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 210-216; DOI: https://doi.org/10.1124/jpet.301.1.210

Z

  1. Zhang, Mei-Yi

    1. You have access
      Identification of a Novel Route of Extraction of Sirolimus in Human Small Intestine: Roles of Metabolism and Secretion
      Mary F. Paine, Louis Y. Leung, H. K. Lim, Kecheng Liao, Aram Oganesian, Mei-Yi Zhang, Kenneth E. Thummel and Paul B. Watkins
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 174-186; DOI: https://doi.org/10.1124/jpet.301.1.174
  2. Zimmerman, Andrew

    1. You have access
      Altered Cardiovascular Responses in Mice Lacking the M1 Muscarinic Acetylcholine Receptor
      Sandrine N. Hardouin, Keith N. Richmond, Andrew Zimmerman, Susan E. Hamilton, Eric O. Feigl and Neil M. Nathanson
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 129-137; DOI: https://doi.org/10.1124/jpet.301.1.129
  3. Zimmerman, Dawn

    1. You have access
      Sustained Activation of p38 Mitogen-Activated Protein Kinase Contributes to the Vascular Response to Injury
      Haisong Ju, Sandhya Nerurkar, Charles F. Sauermelch, Alan R. Olzinski, Rosanna Mirabile, Dawn Zimmerman, John C. Lee, Jerry Adams, Joseph Sisko, Marinella Berova and Robert N. Willette
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 15-20; DOI: https://doi.org/10.1124/jpet.301.1.15
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics: 301 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 301, Issue 1
1 Apr 2002
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts
  • Most Read
Loading
  • Potential Clinical Uses of CBG
  • Ocular Drug Delivery: Past, Present, and Future
  • Rho GTPase–Pathway Inhibitor Reduces Markers of Fibrosis
  • Nose-to-Brain Delivery
  • Stem Cells Therapies in AD
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics